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1 1001-l 67 1 Cardiac Specific Sympathetic Nervous System 
Activation Relates to Hemodynamics and Right 
Ventricular Performance in Mitral Regurgitation 
P. Michael Grossman, Mark A. Supiano, Hakan Oral, Janet A. Petrusha, 
Oscar A. Linares, Rajendra H. Mehta, Mark R. Starling. University of 
Michigan and Ann Arbor VA Medical Systems, Ann Arbor, Ml, USA 
Background: Chronic mitral regurgitation (MR) leads to both left ventricular 
(LV) and right ventricular (RV) dysfunction. It has been previously demon- 
strated that the decrease in RV ejection fraction (EF) correlates with symptom 
status and exercise performance and is a strong predictor of mortality in pa- 
tients (pts) with MR. In addition, the elevation of pulmonary artery systolic 
pressure (PASP) and pulmonary capillary wedge pressure (PCWP) inversely 
correlate with RV EF. We have previously demonstrated that systemic sympa- 
thetic nervous system (SNS) activity is increased as LV end-systolic volume 
enlarges and LV EF fails. This study was designed to test the hypothesis 
that activation of the cardiac specific SNS would be related to pulmonary 
hemodynamics and RV size and performance in pts with chronic MR. 
Methods: Ten MR pts in normal sinus rhythm without coronary artery 
disease had an investigational cardiac catheterization including: gated equi- 
librium radionuclide angiograms for RV EF, placement of a coronary sinus 
catheter, and an infusion of [sH]-norepinephrine (NE) with multiple arterial 
and coronary sinus blood samples during its infusion and decay to provide 
data for a new model of cardiac specific SNS activity. Using an arterial input 
function and deconvolution analysis, total cardiac NE secretion (NEST) and 
fractional cardiac NE production (NE23) were calculated. 
Results: There was a positive correlation between NEBT values and the 
PASPs (r = 0.74, p = 0.01) and pulmonary vascular resistances (PVR) (r 
= 0.93, p < 0.001). The NE3T values correlated inversely with the cardiac 
outputs (r = 0.69, p = 0.03) and, while weakly, inversely with the RF EFs (r 
= 0.62, p = 0.06). The NE23 values correlated directly with the PASPs (r = 
0.73, p = 0.02) and the PCWPs (r = 0.75, p = 0.01) and correlated inversely 
with the RV EFs (r = 0.64, p = 0.05). 
Conclusion: These data suggest that, in patients with chronic MR, car- 
diac specific SNS activity, as reflected by fractional cardiac NE production, 
increases in proportion to an increase in pulmonary pressure and resistance 
and a decrease in RV performance. 
/ 1001-l 68 
12~12 p.m. 
Determinants of lschemic Mitral Regurgitation: 
Are the Papillary Muscles In or Out of the Ring? 
Judy Hung, Mark D. Handschumacher, J. Luis Guerrero, Robert A. Levine. 
Cardiac Unit, Massachuseffs Genera/ Hospital, Boston, MA, USA 
Background: In normal hearts, the papillary muscle (PM) axes are almost 
perpendicular to the mitral valve ring, balancing LV pressure. With ischemia 
and ventricular dilation, the PMs migrate posterolaterally, applying force 
more tangentially to the leaflets and distracting them from coaptation. To 
test the hypothesis that posterolateral migration of the ischemic PM outside 
the mitral annular ring leads to mitral regurgitation (MR), we examined mitral 
valve geometry in 7 sheep using 3D echo, comparing baseline, inferior infarct 
(Ml) from LCX ligation (4 acute, 3 at 8 weeks) and Ml with Physio annular 
ring reduction (22 stages). 
Results: All sheep developed important (moderate-severe) MR with Ml, 
persisting in 6 despite 50 + 18% annular reduction. At baseline, the PM tips 
lay 4-6 mm within the annular ring (shortest distance), viewed in an en face 
projection (left). In all 13 stages with MR, the ischemic PM tip lay up to 11 
mm outside and posterolateral to the ring (right). By multivariate analysis, 
this projected distance was the best MR predictor (p < 0.02), stronger than 
PM-to-anterior annular tethering length. 
Conclusions: MR with segmental ischemia is strongly associated with 
PM migration from within to outside the annular ring in a projected view. This 
displacement, which geometrically could generate forces restricting leaflet 
closure, can be addressed as a potential therapeutic target to overcome the 
limitations of isolated ring reduction. 
12:24 p.m. 
1001-I 69 Relationship Between the Acoustic Propagation 
Properties of the Mitral Valve and the Severity of 
Mitral Regurgitation in Patients With Cardiac 
Amyloidosis 
Hisashi Masugata, Katsufumi Mizushige, Shoichi Senda, Xin Lu, 
Aki Kinoshita, Hirohide Matsuo. Kagawa Medical University: Kagawa, Japan 
Background: Changes in the physical properties of the mitral valve (MV) 
tissue in cardiac amyloidosis (AL), which may be a causative factor of the mi- 
tral regurgitation (MR), have not been described. Tissue physical properties, 
which are expressed by the elastic bulk modulus (reciprocal of compress- 
ibility), can be evaluated by tissue sound speed. The tissue sound speed is 
given by c = JWp, where c is the tissue sound speed, K is the elastic bulk 
modulus, and p is the density. A reduction in tissue sound speed indicates 
a reduction in the elastic bulk modulus and a greater compressibility of the 
tissue. This suggests that the tissue is soft. The purpose of this study was 
to assess the physical properties of MV tissue by evaluating the acoustic 
propagation properties (i.e. tissue sound speed) of the MV tissue in AL. 
Methods: MV specimens at autopsy were obtained at autopsy from 20 
control subjects without cardiovascular disease and from 18 patients with 
AL. An acoustic microscope operating at 450 MHz was used to measure 
the tissue sound speed in the rough and clear zones of the MV tissue. The 
severity of the MR had been evaluated by Doppler echocardiography as the 
MR jet area before death, and it was compared with the tissue sound speed 
measured after. 
Results: In AL showing mild MR (MR jet area < 1.0 cm’), the tissue 
sound speed of the MV in the rough zone (1605 f 19 m/s) and in the clear 
zone (1791 f 64 m/s) were lower than the corresponding values in control 
subjects (1637 f 42 m/s and 1851 j: 62 m/s). However, these differences 
were not significant. In AL showing moderate MR (MR jet area 2 1 .O cm2 
and 15.0 cm”), the tissue sound speed of MV in the rough zone (1563 i- 17 
m/s) and in the clear zone (1654 f 59 m/s) were significantly lower than the 
corresponding values in the control subjects (p < 0.001). The magnitude of 
the MR evaluated by color Doppler echocardiography correlated negatively 
with the MV tissue sound speed of the rough zone (r = -0.868, p < 0.0001) 
and the clear zone (r = -0.513, p = 0.0296) in the patients. This correlation 
was stronger in the rough zone than in the clear zone. 
Conclusion: The low value of the MV tissue sound speed in patients with 
AL indicated a reduced elastic bulk modulus suggesting the softentng of the 
MV tissue. Furthermore, the degree of reduction in the tissue sound speed 
correlated clearly with the magnitude of the MR, especially in the rough zone. 
The data suggest that the changes in physical properties of the MV tissue 
may be one of important causes of MR in AL. 
12:36 p.m. 
1001-l 70 The Natural History of Fenfluramine-Associated 
Valvulopathy Assessed by Echocardiography 
Steven T. Mast, James G. Jollis, Thomas Ryan, Carolyn K. Landolfo, Jack 
L. Crary. Duke University Medicai Center, Durham, NC; MeritCare Medical 
Center, Fargo, ND, USA 
Background: An association between the dietary suppressant fenfluramines 
and valvular heart disease was first described among a cohort of patients from 
North Dakota and Minnesota in 1997. The natural history of this valvulopathy 
remains unknown. 
Methods: We compared serial echocardiograms among 18 patients in 
the original report, and 32 additional patients presenting to MeritCare Medical 
Center in Fargo, ND who met FDA criteria for fenfluramine-associated valvu- 
lopathy to determine disease progression after stopping the medication. The 
mean duration of drug exposure was 13 months. Echo-Doppler studies were 
reviewed by two cardiologists blinded to the order of acquisition to assess 
the severity of valvular regurgitation and leaflet thickening or restriction. 
Results: As described in the initial report, moderate to severe valvular 
disease was relatively common among this cohort (n = 50) on initial post- 
exposure echo [mitral regurgitation (MR)-mild 8 pts (16%), moderate 9 (18%), 
severe 12 (24%); aortic regurgitation (AR)-mild 9 (18%), moderate 13 (26%), 
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severe II (22%)]. The change in severity of regurgitation on follow-up ethos 
performed a mean of 12 months following the initial post-exposure echo is 
displayed below: 
% Patients 
Im+zwing 21 grade 
Without change 
Worsening ~1 grade 
MR AR 
34% 38% 
58% 54% 
8% 8% 
For the majority of patients, the degree of valve regurgitation was un- 
changed. Among patients whose regurgitation changed, more were likely to 
show improvement of at least one grade (P < 0.05), including two patients 
whose severe regurgitation at baseline was considered mild on follow-up. 
Conversely, further deterioration was uncommon, which may be partly at- 
tributable to the substantial number of patients who were initially graded as 
severe. 
Conclusion: This is the first description ,of the natural history of fenflu- 
ramine-associated valvular disease. The regression of valvular regurgitation 
occurring in some patients should be taken into account when considering 
the timing of valve surgery. 
12:48 p.m. 
Exl 1001 171 Natural History of Right and Left Ventricular Size 
and Function in Patients With Asymptomatic 
Chronic Severe Non-lschemic Mitral 
Regurgitation 
Glare A. Hochreiter, Jeffrey S. Borer, Dori A. Engel, Richard B. Devereux, 
Mary J. Roman, Paul D. Kligfield, Edmund M. Herrold, Phyllis G. Supino, 
Nora I. Bergsten. Cornell Univers& New York, New York, USA 
Background: We and others have previously shown that right ventricular 
(RV) and left ventricular (LV) ejection fraction (EF) at rest and/or during 
exercise are of prognostic value in patients with mitral regurgitation (MR). 
However, the optimal interval between non-invasive assessments of these 
parameters to identify development of “high risk” (for heart failure or sudden 
death) is not known. Knowledge of the rate of change of RV and LVEF and 
of cardiac dimensions should guide the frequency of serial studies. 
Methods: Thus, as part of an ongoing study of chronic non-ischemic MR, 
we determined the av (and fastest) annual rate of change in heart size (n 
= 22) and EF (n = 22) among initially asymptomatic/minimally symptomatic 
patients (av 50 yo, range 20-69 yr, 61% men) with severe MR, with av follow 
up > 6 yrs and av > 5 serial studies. 
Results: 
Averaoe Rate of Chanae Fastest Rate of Chanoe 
LVlDd 
LVlDs 
LA 
LVEFrest 
LVEFexercise 
A LVEF 
RVEFrest 
RVEFexercise 
A RVEF 
0.04 cm/year 
0.03 cm/year 
0.08 cm/year 
-0.03%/year 
-O.G%/year 
-05%iyear 
-0.4%/year 
-0.8’Wyear 
-0.3%/vear 
0.29 cm/year 
0.04 cm/year 
0.18 cm/year 
-l.Z%/year 
-2.6%lyear 
-2.8Wyear 
-1.7%lyear 
-2.7%iyear 
-3.l%/vear 
LVIDclk: LV diastolic/systolic dimension; LA: left atrial dimension; A: change from rest to 
exercise. 
Conclusion: On average, LVEF and RVEF decrease slowly over time 
(rest, exercise, A); LV and LA dilatation similarly develop slowly. However, 
maximum change is such that patients with resting EF values in the lower 
range of normal, or with minimum A, can move from low to high risk within 
one year (particularly ARVEF). Therefore, the appropriate rate of serial study 
in asymptomatic pts can be guided by knowledge of baseline values and av 
rates of change but need not be more frequent than annual, and probably 
should not be substantially longer. 
I:00 p.m. 
1001-I 72 A New In Vivo Model Providing a Direct Gold 
Standard for Mitral Regurgitant Flow 
Quantification. Application to Validate a New 
Doppler Method 
Thomas Buck, J. Luis Guerrero, Mark D. Handschumacher, Robert 
A. Levine. Massachusetts General Hospital, Boston, MA, USA 
Background: In vivo testing of new noninvasive methods for improved mitral 
regurgitant (MR) flow quantification lacks ideal standards. Previous flowmeter 
methods are indirect with uncertain baselines. We therefore developed a new 
canine model to measure MR volume directly and unambiguously. 
Methods: In anesthetized, ventilated dogs, the left atrium was replaced 
by a nondistensible chamber sutured to the mitral annulus via a Dacron 
ring. This chamber was attached to a 1 .O-cm diameter column, within which 
MR stroke volume (MRSV) produced a vertical fluid excursion with each 
systole (1.3 cm = 1 ml). Pulmonary veins were ligated and, using ‘right 
heart bypass, venous return was collected, oxygenated and pumped into 
the LV. We tested this model with the new Doppler power-velocity integral 
(PVI) method for direct MR flow quantification validated before in vitro. 36 
hemodynamic stages were analyzed in 3 dogs with MR orifices of 0.12 to 
0.21 cm2 cut into the anterior leaflet. 
Results: For each hemodynamic stage, MRSV reading was stable over 
the recording time (IO-20 beats). MRSV by direct reading and PVI correlated 
well (r = 0.98, y = 0.98x + 0.28 ml, mean error = 0.04 f 0.87 ml, p = NS vs. 
0). 
Conclusion: This model provides for the first time a directly measured 
gold standard for validating quantitative measures of mitral regurgitation. 
1:12 p.m. 
ELI 1001 173 Late Results of Valve Repair in 58 Patients Referred in the 80’s for Rheumatic Mitral 
Regurgitation 
Richard Bonhomme, Pierre Michaud, Bernard lung, Eric Garbarz, 
Patricia Berdah, Joel Kamblock, Philippe Lionet, Gerard Papouin, 
Alec Vahanian. Tenon Hospital, Paris, France; Mamao Hospital, Papeete, 
French Polynesia 
Background: Late results of valve repair (VR) are thought to be less satisfy- 
ing in rheumatic than degenerative mitral regurgitation (MR). However, late 
results of VR using contemporary techniques are not well known, particularly 
in young patients (pts) in whom there is no ideal valvular substitute. 
Methods: Between 1990 and 1997, 58 pts underwent mitral VR for pre- 
dominant rheumatic MR. Mean age was 39 f 18 years; 34 pts (59%) were 
in NYHA class I or II, 18 (31%) had atrial fibrillation, and 28 (48%) a history 
of heart failure. Mean left ventricle ejection fraction was 56 f 9% and mean 
end diastolic diameter 61 * 7 mm. Surgical findings were partial commis- 
sural fusion in 37 pts, restrictive valvular motion in 54 and valve prolapse in 
14. Ring. annuloplasty was performed in 57 pts, leaflet resection in 6, leaflet 
enlargement with a pericardial patch in 4, procedure on the chordae in 17, 
and commissurotomy in 35. Other procedures were CABG in 3, tricuspid 
annuloplasty in 3, and aortic valve surgery in 15. 
Results: There was no operative death. Post-operative echocardiography 
showed no or grade 1 MR in 49 pts, grade 2 in 7 and grade 3 in 2, 1 requiring 
early valve replacement, Mean valve area was 2.4 & 0.4 cm’, [I .5 to 3.4, 6 
pts having ~2 cm”]. 
During a mean follow-up of 43 months (up to 102), events were 2 deaths 
(1 cardiac) and 5 other reoperations: 4 cases of valve replacement for 
subsequent deterioration, and 1 tricuspid repair. The 6 year survival rate with 
no reoperation and an NYHA class I or II was 68 f 10% and its predictor in 
multivariate Cox analysis was the post-operative APm (p = 0.03). 
Conclusion: f) Mitral VR provides good late results in selected pts with 
rheumatic MR, in particular in young pts. 2) Post-operative APm identifies 
pts with high risk of subsequent deterioration. 
I:24 p.m. 
1001-t 74 Five-Year Follow-Up After Mitral Valve 
Replacement With a Cryopreserved Homograft 
Patricia Berdah, Bernard lung, Eric Garbarz, Philippe Lionet’ , 
Joel Kamblock’ , Pierre Michaud, Bruno Farah, Bertrand Cormier, 
Gerard Papouin’ , Alec Vahanian. Tenon Hospital Paris, France; ‘Mamao 
Hospital, Papeete, French Polynesia 
Background: Cryopreserved homograft (CH) has been recently proposed 
as a new substitute for mitral valve replacement (MVR). The main concern is 
related to the structural evolution of the homograft and mid-term results have 
not been reported so far. 
Methods: Between 1993 and 1998, 51 patients (pts) underwent MVR 
using a CH. Their mean age was 35 +I 15 years 110-691, 30 pts (59%) were 
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in NYHA class Ill or IV, and 40 (78%) in sinus rhythm. The indications for MVR 
were rheumatic disease in 37, endocarditis in 11 pts, and miscellaneous in 
3. Total CH was implanted in 33 pts and partial CH in 18. 
Results: Post-operative complications were 3 deaths (6%) and 3 cases 
(6%) of early dysfunction of homograft with grade 3 regurgitation requiring 
valve replacement. Post-operative valve area (VA) was 2.2 & 0.4 cm’. There 
were 14 cases of grade I regurgitation and no grade 2. 
Mean follow-up (FU) was 30 months [l-73]. The 5-year rate of survival 
with no reopeartion and in NYHA class I or II was 69 f 9%. There was 1 
non-cardiac death and 3 late reoperations after 1 year (stenotic evolution), 
4 years (deterioration of aortic repair), and 5 years (endocarditis on CH). All 
other patients were in NYHA class I or II at last FU. FU TTE showed VA of 
2.0 i 0.4 cm2 [i .O-2.61, with 3 patients having cl.5 cm? 11 pts had grade 
1 MR and 1 grade 2 MR while no pt had regurgitation >2/4. 
Conclusion: VR using CH provides satisfactory mid-term clinical results 
and TTE FU shows continuing good valve function in most pts. Cases of 
early dysfunction and late deterioration underlines the necessity of a longer 
FU to evaluate this technique. 
I:36 p.m. 
1001-I 75 Comparative Indications, Baseline 
Characteristics and Results of Percutaneous 
Mechanical Mitral Commissurotomy in Western 
and Developing Countries 
Hel8ne Eltchaninoff, Ramesh Arora, Sriram Rajagopal, Subash Chandra, 
Sameer Dani, Anil Bhat, Pratap Rath, Alain Cribier. For the investigators of 
the Mukicenter Registry; H6pifal Charles Nicolle, University of Rouen, 
France 
Backgrounds: Due to marked differences in the baseline characteristics of 
patients with mitral stenosis (MS), balloon mitral valvuloplasty is associated 
with less favorable results in western than in developed countries. Percuta- 
neous Metallic Mitral Commissurotomy (PMMC) has been developed since 
1996 as an alternative technique for the treatment of MS. From the ongoing 
international registry of PMMC (13 countries, 817 patients), we compared the 
safety and efficacy of this new technique in two populations with known dif- 
ferent baseline characteristics: France (88 patients) and India (451 patients). 
Methods: Baseline clinical, echocardiographic and hemodynamic data, 
and the immediate results: mitral valve area (MVA, assessed at day 1 by 
2-D echocardiography), complications, and procedural success (final MVA 
> 1.5 cm2 with no MR > 2) were compared in the two groups. Complica- 
tions included death, tamponade, mitral regurgitation (MR) z grade 2 on 
angiography and stroke. 
Results: 
Age (years) 
Prior commissurotomy 
0 left atrium (mm) 
Wilkins score/l6 
MVA (cm’) base 
Gradient (mmHg) base 
PA (mmHg) base 
Final MVA (cm’) 
A MVA (cm2) 
Final gradient (mmHg) 
Success rate 
Complications 
55+12 31 i10 <0.0001 
24% 12% 0.005 
51 -I 8 47*7 <0.0001 
813 7zt2 0.006 
1 .o i 0.3 0.8 zk 0.2 <0.0001 
12f6 20 f 7 <0.0001 
41 i-16 60 + 25 <0.0001 
2.0 * 0.5 2.1 i 0.3 0.02 
l.OiO.4 1.3 * 0.4 <0.0001 
513 4+3 0.001 
88% 96% <0.002 
3 (3.4%) 15 (3.3%) NS 
Six patients (1 .l%) had tamponade (leading to death in one), 9 (1.7%) 
developed severe MR and 3 (0.6%) had a stroke. 
Conclusion: In France, the population with mitral stenosis is older, with 
more distorted valve, more prior commissurotomy but less tight stenosis than 
in India. PMMC is comparably safe in the 2 populations but is associated 
with a higher procedural success rate and a slightly better final valve area in 
India. 
I:48 p.m. 
1001-I 76 Long Term Results of Mitral Balloon Valvotomy 
in Pregnancy 
Abdulhalim J. Kinsara, M.E. Fawzy, V. Sivanandam, 0. Ismail, H. Kattan. 
5.Khan.King Faisal Specialisf Hospital & King Khalid Hospital, Saudi Arabia 
Background: Mitral balloon valvotomy (MBV) during pregnancy have been 
done as an alternative procedure for Surgical commissurotomy in patients 
with severe mitral stenosis (MS). Several reports have shown favorable 
immediate results, however there is no report on long term results. 
Aim: To study the immediate and long term outcome of MBV in pregnant 
patients with severe MS, and its outcome on babies. 
Methods: 20 pregnant patients underwent MBV during second trimester 
using lnoue balloon, for severe MS with dyspnea NYHA-classification class 
3-4, the patients were followed from 6-85 months (mean of 55 i 26). 
Results: The procedure was successful in all patients. The immediate 
mitral valve area (MVA) increased from 0.9 f 0.2 to 2.0 f 0.4 cm2 by Echo 
Doppler (p < O.OOOl), mitral mean gradient decreased from 15 i 5 to 6 & 
2 mmHg (p < O.OOOl), 4 patients had mild worsening of mitral regurgitation 
and 7 patients had insignificant ASD. There was no mortality. All patients 
had uneventful pregnancy with improvement in NYHA class, 19 had normal 
delivery and one had cesarean section at 36 weeks resulting in stillbirth. The 
birth weight ranged from (25-50 percentile). All the babies were normal. 
On Long-term follow-up, MVA was 1.8 f 0.4 cm’, 3 patients (15%), 
had restenosis with MVA < 1.2 cm2, The babies maintained normal growth, 
development and speech for age, one baby died at one week of age and 
another at 8 months. 
Conclusion: MBV is the treatment of choice for severe MS during preg- 
nancy and long term follow-up of patients and their babies is satisfactory. 
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1026-63 Experimental Hypercholesterolemia Induces 
Atherosclerosis and Osteopontin Expression in 
Aortic Valves 
Nalini M. Rajamannan, Margarett Springett, Jin Ho Kang, Geoff Gleason, 
Angela Wood, Benjamin Drinkal, William D. Edwards, A.J. Tajik, Robert 
S. Schwartz. Mayo Clinic, Rochester, MN, USA 
Background: Hypercholesterolemia is a risk factor for vascular atheroscle- 
rosis and calcification. Osteopontin is known bone matrix protein identified 
in the plaques of atherosclerotic lesions and calcified aortic valves. How- 
ever, the mechanism by which calcification occurs is unknown. We studied 
a model of experimental hypercholesterolemia to define the development of 
atherosclerotic lesions in the aortic valve. We also evaluated osteopontin ex- 
pression, a non-collagenous bone matrix protein in the hypercholesterolemic 
aortic valves. 
Methods: New Zealand rabbits (n = 8) were fed with a 1% cholesterol diet 
for 12 weeks. Eight control animals were fed a normal chow diet. Aortic valves 
were cut and foam cells were identified by immunostaining for macrophage 
antibody. Cell proliferation was assessed by immunostaining for proliferating 
nuclear antigen (PCNA), and osteopontin (OP) for calcification. Transmission 
electron microscopy immunogold labeling confirmed osteopontin expression. 
Results: Atherosclerotic lesions were present in all cholesterol treated 
rabbit valves as compared to controls. These lesions stain positive for foam 
cell formation. There was increased osteopontin expression in the athero- 
sclerotic lesion of the aortic valves and a thousand-fold increase in the 
number of proliferating cells as compared to the controls. Cholesterol lev- 
els in the rabbits: the cholesterol treated rabbits had a cholesterol level of 
1036 f 96 mgidl, the normal rabbits had a cholesterol level of 42.28 i 24 
mg/dl. Osteopontin expression was confirmed by immunogold labeling in the 
hypercholesterolemic valves. Electron microscopy analysis determined that 
immunogold label is present primarily in matrix vesicles embedded in colla- 
gen fibrils which is characteristic of calcification. Furthermore these heavily 
labeled areas are enriched in cholesterol deposition. 
Conclusion: Hypercholesterolemia induces an atherosclerotic lesion in 
rabbit aortic valves, as evidenced by foam cell infiltration and an increase 
in cellular proliferation. Furthermore, there was stimulation of osteopontin 
production which is a marker of bone matrix development. Hypercholes- 
terolemia may stimulate the calcification process present in calcific aortic 
valve disease. 
1026-64 Increased Activity of Matrix Metalloproteinases in 
Floppy Aortic Valves 
Koichi Tamura, Takemi I-ida, Masamichi lshizaki, Goro Asano, 
Sigeo Tanaka, Victor J. Ferrans. Nippon Medical School, Tokyo, Japan; 
National lnstifutes of Health, Bethesda, Mary/and, USA 
Background: As in floppy mitral valves (FMVs), damage to collagen and 
elastin is considered important in the pathogenesis of floppy aortic valves 
(FAVs). However, the mechanism of this damage is unclear. The lysis of 
collagen and elastin is regulated by the balance between the matrix metal- 
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loproteinases (MMPs) and their tissue inhibitors (TIMPs). Since increased 
activity of MMPs has been demonstrated in FMVs, the present study was 
made to determine whether similar changes occur in FAVs. 
Methods: Gross anatomic, histologic and ultrastructural studies were 
made of 12 FAVs resected at the time of aortic valvular replacement for 
aortic regurgitation. lmmunohistochemical studies were made of the activity 
of MMP-I, MMP-2, MMP-3, MMP-9, TIMP-I and TIMP-2 in 7 of these FAVs. 
Gelatin zymography was performed in 3 FAVs. Three normal aortic valves 
obtained at autopsy served as controls. 
Results: Two types of FAVs were recognized grossly, according to 
whether they showed abnormal cuspal thickening (n = 7) or thinning (n = 
5). Accumulations of myxoid material in the spongiosa were found in all 
FAVs, regardless of cuspal gross morphology. Ultrastructurally, the myxoid 
material consisted of star-shaped proteoglycan granules associated with spi- 
raling collagen fibrils and elastic fibers with a granular appearance. Staining 
for MMP-1, MMP-2 and TIMP-1 was increased in fibroblasts and interstitium 
in myxomatous areas of FAVs, compared to that in the spongiosa of normal 
aortic valves, but staining for TIMP-2 was unchanged. Gelatin zymography 
showed the activated form of MMP-2 to be present in FAVs, but not in normal 
aottic valves. 
Conclusion: Abnormalities in connective tissue components are similar 
in FAVs and FMVs. Increased activity of MMPs (especially MMP-2) and 
imbalance between MMPs and their corresponding TlMPs may cause an 
increase in collagenolytic and elastolytic activity, and may be responsible for 
the morphologic changes in FAVs. 
1026-65 Higher Prevalence of a Vitamin D Receptor Allele 
in Patients With Calcified Aortic Valve Stenosis 
JR Ortlepp, F. Ohme, F. Bleckmann, J. vom Dahl, P. Hanrath. Medical 
Clinic I, University Hospital Aachen, Germany 
Background: Degenerative calcification of sot-tic valves is the most com- 
mon cause of valvular aottic stenosis. Despite clinical factors associated 
with coronary artery disease have been shown to be associated with calci- 
fied aortic stenosis other factors must be important for the development of 
the pathomorphological changes of the valve since 50% with severe aottic 
stenosis have no coronary artery disease. Genetic polymorphisms with are 
associated with alteration of the calcium homeostasis might be one of those 
factors. 
Methods: The distribution of one polymorphism of the vitamine D receptor 
(VDR Bsml B/b) in 100 consecutive patients with calcified valvular aortic 
stenosis and 100 controls was examined using PCR und RFLP. The control 
group of 100 patients was paired matched for age, sex and presence of 
coronary artery disease out of 630 patients without calcified aortic valve. In 
all patients coronary angiography was performed. 
Results: The VDR polymorphism showed a significant difference in allele 
and genotype frequencies in both groups. The VDR allele B, which is asso- 
ciated with a lower bone mineral density and higher serum levels of calcitriol 
and parathormone, has a significant (p = 0.001) higher prevalence in patients 
with calcified aortic stenosis (B = 0.56, b = 0.44) than in controls (B = 0.40, b 
= 0.60). 
Conclusion: We conclude that the B allele of the vitamin D receptor, 
which has a pysiological meaningful function, predispose gene carriers for 
extraosseous calcification like calcified aortic valve stenosis. If other genes, 
which control the calcium homeostasis, are involved in the pathogenesis of 
calcified aortic valve stenosis has to be shown. 
1 1026-66 1 C-Reactive Protein and Chlamydia Pneumoniae 
Titres in Patients With Aortic Sclerosis on 
Echocardiographic Evaluation 
Harish R. Chandra, Pamela A. Marcovitz, Nivedita Choudhary, 
Carol O’Neill, Peter B. George, Sreenivasulu R. Gangasani, Lynn Cronin, 
William W. O’Neill. William Beaumont Hospital, Royal Oak, Ml, USA 
Background: Several recent studies have demonstrated that aottic sclerosis 
is not a benign condition and have shown its association with atherosclerotic 
heart diseases. Inflammation and infection with Chlamydiapneumoniae have 
been implicated in the pathogenesis of various atherosclerotic lesions of the 
cardiovascular system. 
Methods: We looked at the association between C-Reactive protein 
(CRP) and Chlamydia pneumoniae titre (CPIgG) levels in a cohort of patients 
2 65 years of age (n = 259) who were admitted to the chest pain center 
of our hospital and had echocardiographic evaluation with Doppler studies. 
Blood tests and clinical information were obtained at the time of the visit. 
Prospective and blinded evaluation of echocardiograms were clone for the 
diagnosis of aortic sclerosis (including calcification and focal thickening of 
the aortic valve). 
Results: Mean age of the patients was 77 f 7 years, 52% were females 
and 89% were Caucasian. 57% of the patients had known history of coro- 
nary artery disease, 29% had diabetes, 76% had hypertension, 44% had 
hyperlipidemia, 26% had congestive heart failure and 44% were current or 
ex-smokers. Overall, 64% of the patients had aortic sclerosis. The group with 
aortic sclerosis was older (78 f 8 yr.) compared to the group with normal aor- 
tic valves (75 i 6 yrs., p = 0.006) and had a higher serum creatinine level (1.5 
4 1.3 mg/dl vs. 1.2 & 0.6 mg/dl, p = 0.013). There was no difference in the 
prevalence of coronary artery disease, hypertension, diabetes, congestive 
heart failure, hyperlipidemia, current or past smoking, and obesity between 
the groups. After adjustment for age, sex, and serum creatinine levels, there 
was a statistically significant association between aottic sclerosis and CRP 
level (odds ratio, 1 .I 5; p = 0.03), and CPlgG titre ? 1512 (odds ratio, 1.97; 
p = 0.03). 
Conclusion: There appears to be a significant association between aortic 
sclerosis, and C-Reactive protein and seropositivity to Chlamydia pneumo- 
niae. There is need for further studies to better elucidate the relationship 
between aottic sclerosis and inflammation as well as infection with Chlamy- 
dia pneumoniae. 
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LIZI 1047 63 Active Rheumatic Cardltis in Children: An Acute and Follow Up Study of 155 Patients in the Era of 
Echo Dopplei - 
Anita Saxena, Mridul Sharma, Dhiraj Gupta, Shyam S. Kothari, 
Rajneesh Juneja. Department of Cardiology, A// lndia institute of Medical 
Sciences, New De/hi, lndia 
Background: The role of serial echo-Doppler examination in the diagnosis 
and management of patients of acute rheumatic fever (ARF) has not been 
defined. 
Methods: We studied 155 consecutive children ii2 years of age with 
proven acute rheumatic carditis (first episode in 130). 94 were males and the 
mean age was 9.3 + 2.1 years. A detailed baseline echo-Doppler was per- 
formed to look for presence and severity of mitral regurgitation (MR), aortic 
regurgitation (AR), left-ventricle (LV) size and function, ‘nodules’ on valves 
leaflets (previously described from our centre as being specific for ARF), 
leaflet prolapse and pericardial effusion. All patients received 12 weeks of 
steroid therapy. 130 (83.8%) patients were followed up for a mean follow-up 
(FU) interval of 45.3 f 26.8 months with FU echo-Doppler (in clinical remis- 
sion) done in 112 (72.3%) cases. 
Results: At presentation, 69 (44.5%) patients were in NYHA class III/IV of 
which 29 (18.7%) patients were in congestive heart failure. Only 27 (17.4%) 
were in NYHAclass I. The cardiac lesions observed were isolated MR in 108 
(69.6%) cases, combination of MR and AR of varying severity in 45 cases 
and isolated AR in 2 cases. 51 (33.2%) patients had severe MR. Only 2 
patients (both with ARF recurrence) had mitral stenosis. Valvular rheumatic 
nodules were seen in 50 (32.2%) cases, pericardial effusion in 26 (16.8%) 
cases and evidence of mitral leaflet prolapse in 16 (10.3%). Although LV 
dilatation was seen in 96 (61.9%) cases, the LV function was normal in all 
(mean LVEF 60.2 f 8.4%, range 52-74%). At the FU Doppler examination, 
the severity of MR decreased by at least 1 grade in 69 (61.6%) patients 
(disappearing completely in 11) and increased in only 4 (3.6%) cases (p < 
0.001 as compared to baseline examination). This decrease in MR severity 
was more often seen following the first episode of ARF (76.5% vs 48.2%, p 
= 0.04). The severity of AR remained the same in the majority of patients (20 
of 28.71%, p = 0.24). However, in two patients severe AR showed complete 
regression. The FU echo-Doppler also showed a significant decrease in the 
prevalence of leaflet nodules (3%, p c 0.001) and pericardial effusion (2% 
p < 0.001). Recurrence of RF occurred in 13 cases (8.3%), all of whom 
had missed penicillin prophylaxis. Over the FU period, 24 (15.4%) patients 
progressed to the point of requiring valve surgery. 
Conclusions: Echo-Doppler examination plays an invaluable role in the 
diagnosis and follow-up of patients with acute rheumatic cardctis. Following 
resolution of activity, the majority of MR lesions show regression in severity 
while most AR lesions do not. As shown even in this group of relatively ‘sick 
patients, the overall prognosis is good, especially in those compliant with 
regular penicillin prophylaxis. 
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I 1047 64 Evidence of Ongoing Inflammation in Chronic Rheumatic Mitral Valve Disease 
Nitin K. Ghaisas, J. Brendan Foley, D. Sean O’Briain, Peter Crean, 
Dermot Kelleher, Michael Walsh. Department of Cardiology, St James’s 
Hospital, Dublin, UK 
Background: Inflammatory cells have been demonstrated in chronic rheumatic 
mitral valve (MV) disease. Adhesion molecules are important in the local- 
ization of leukocytes to areas of inflammation. We studied expression of in- 
tercellular adhesion molecule-i (ICAM-I), vascular cell adhesion molecule-l 
(VCAM-1) and endoihelial selectin (E-selectin) on valvular endothelium, their 
relation with soluble adhesion molecule levels, and the effect of surgery on 
serum levels at 6 and 18 months post-operatively. 
Methods: Valves from 9 patients with rheumatic MV disease undergoing 
surgery, and 4 from autopsy specimens (3 normal, 1 thickened) were studied 
for adhesion molecule expression by immunohistochemistry. Staining was 
graded independently from O-l (12 considered positive). Soluble ICAM-1, 
VCAM-I and E-selectin in peripheral blood were measured by ELISA pre- 
operatively, and at 6 and 18 months post-operatively. 
Results: 8 of 9 (89%) MV were positive for ICAM-1, 5 of 9 (56%) for 
VCAM-1, and 4 of 9 (44%) for E-selectin. All 3 soluble adhesion molecules 
were elevated compared with matched controls. There was no association 
between endothelial staining and soluble molecule levels for any of the 
molecules. One of 3 normal autopsy valves (33%) stained positive for ICAM-I 
while none stained for VCAM-1 or E-selectin. The single thickened valve 
was positive for all three adhesion molecules. On serial sampling E-selectin 
levels fell significantly at 18 months post-operatively, while slCAM-I rose, 
and sVCAM-I levels did not change significantly. 
Conclusions: Increased endothelial expression and increased levels of 
soluble adhesion molecules suggest ongoing active inflammation in chronic 
rheumatic mitral valve disease. 
1047-65 Safety and Feasibility of Percutaneous Mitral 
Valvotomy With the Metallic Commissurotome in 
Patients \iYith a High Echocardiographic Score 
Genevieve Derumeaux, Helene Eltchaninoff, Rene Koning, Alain Crib&. 
For the hvesfigafors of the Multicenter Registry; Rouen Universif~ France 
Background: Severe mitral calcifications and retracted sub-valvular appara- 
tus leading to a high echo-score (SC) usually represent a contra-indication to 
percutaneous balloon mitral valvuloplasty, because of poor immediate results 
and increased risk of mitral regurgitaion (MR). 
Methods: A new metallic commissurotome was developped and used 
in a series of 755 patients (Pts) divided into 3 groups: 385 Pts with low 
SC (<8/16), 229 with mild SC (8-906) and 105 with high SC >10/16). Our 
purpose was to evaluate the feasibility and safety of mitral valvotomy in high 
SC Pts vs low- and mid SC Pts. 
Results: In the high SC group, SC was 10116 in 55%, ii/16 in 28%, 1206 
in 10% and >13/16 in 7%. Thickening of mitral valve was scored 3/4 in 
70% and 414 in 10%. Calcifications were scored 3/4 in 31% and 4/4 in 9%. 
Sub-valvular apparatus was severely retracted in 69%. High SC Pts were 
significantly older and 26% had a previous balloon valvotomy vs 9% in low 
SC and 16% in mid SC (p < 0.001). Pre-valvotomy mitral value are (MVA, 
cmp) by planimetry was similar in high SC (0.89 i 0.4), low SC (0.95 & 0.2) 
and mid SC (0.93 f 0.2). Number of openings (2 to 4) was similar in the 3 
groups and maximal opening size (40 mm) was used in 85% of low SC, 92% 
of mid SC and 89% of high SC (p = 0.03). 
The procedure was successful (MVA < 1.5 and MR 5 2/4 of Sellers 
classification) in 96% of low SC, 94% of mid SC and 82% of high SC (p < 
0.0001). Mean absolute increased in MVA was 1.24 rt 0.4 in low SC, 1 .I6 i 
0.4 in mid SC and 1 .Ol & 0.6 in high SC (p < 0.001). Post-valvotomy MVA was 
slightly lower in high SC (1.92 i 0.4) than in mid SC (2.09 =t 0.3) and in low 
(2.18 & 0.4) (p < 0.0001). Double commissural splitting was obtained in 88% 
of low SC, 82% of mid SC and 74% of high SC (p < 0.01). Minor complications 
occurred in 2% of high SC vs none in low SC and 2% in mid SC whereas 
major complications (3 transient strokes, 16 MR, 10 tamponnades and 1 
death) occurred in 8% of high SC vs 6.5% in mid SC and 3% in low SC (p < 
0.001). The best predictor of complication was the retraction of sub-valvular 
apparatus whereas calcifications, valve thickening and mobility did not affect 
the immediate results nor the prognosis. 
Conclusion: Percutaneous mechanical mitral valvotomy appears feasi- 
ble, efficient and safe in Pts with a high echo-score, especially when the 
sub-valvular apparatus is not retracted. Therefore, it might be proposed as 
an alternative to surgery in high surgical risk Pts. 
Dobutamine Stress Echocardiography, 
Cardiopulmonary Exercise Test and Exhaled 
Nitric Oxide in Patients With Pure Mitral Stenosis 
Mara Morello, Roberta Casoni, Cosimo Greco, Pierluigi Omede’, 
Paola Colagrande, Lucia Mangiardi. Divisione Universifaria di Cardiologia, 
Universif2 di Torino, Ospedale Molineffe, Torino, lfalia 
Background: Previous reports have demonstrated that symptomatic patients 
(pts), with mild or moderate mitral stenosis (MS) and low functional capacity, 
have significant increase of pulmonary artery systolic pressure (PAP) despite 
a little change in transmitralic gradient. Nitric oxide (NO) is known to modulate 
the pulmonary vascular tone. 
Aim: 1) to evaluate PAP during dobutamine stress echocardiography 
(DSE) in pts with pure MS and different levels of functional capacity and 2) 
to verify whether NO plays a role in the regulation of PAP at rest and during 
exercise. 
Methods: Study population included 37 pts: 30 women; aged 28-72 
years: 16 pts had atrial fibrillation; 8 pts were in NYHA class I, 21 pts were in 
NYHA class II and 8 pts were in NYHA class Ill. All pts underwent cardiopul- 
monary exercise test. Before and at the end of the exercise test exhaled air 
was collected in a bag. The exhaled NO output was calculated by measuring 
NO concentration with chemiluminescence analyzer and minute ventilation. 
NO output at rest and after exercise was determined in IO normal subjects. In 
a different day DSE was performed: mitral valve area, transmitralic gradient, 
stroke volume and PAP were measured at rest and during ecostress with 
dobutamine infusion (5-40 qgikglmin). 
Results: Pts were divided in 2 groups: A, 16 pts with impaired functional 
capacity at cardiopulmonary exercise test (observed maximal oxygen uptake 
~75% theoretic maximal oxygen uptake) and B, 21 pts with normal functional 
capacity. Basal echocardiographic data were not different in the two groups. 
Group A had a significantly higher PAP (68.8 + 2.75 vs 45 + 7.6 mmHg 
p < 0.01) during DSE and lower NO output (181.4 f 73.4 nl/min) after 
exercise as compared to group B (414.2 & 153.3 nl/min) and normals (511 .I 
f 126.1 nlimin). NO output was inversely correlated to PAP measured during 
ecostress (r = -0.69). 
Conclusion: 1) Our study confirms that, during ecostress, PAP increases 
more than transmittal gradient in pts with MS and impaired functional capacity. 
2) The inverse relationship between NO output and DSE induced increase 
in PAP supports the role of NO in regulating pulmonary vascular tone. 
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1070-63 Altered Glycosaminoglycan Distribution in 
Myxomatous Mitral Valves 
K. Jane Grande-Allen, Brian P. Griffin, Norman B. Ratliff, Delos M. Cosgrove 
Ill, Ivan Vesely. Cleveland Clinic Foundation, Cleveland, Ohio, USA 
Background: Myxoid mitral valve disease is now the leading cause of mitral 
valve dysfunction. Although there is some uncertainty about the specific 
cause and extent of myxoid changes, it has been reported that myxomatous 
mitral valves have an increased total glycosaminoglycan (GAG) content. 
Our study was designed to measure the relative amounts of different GAG 
types in normal and myxomatous mitral valves using fluorophore-assisted 
carbohydrate electrophoresis (FACE). 
Methods: Myxomatous mitral valves were obtained from pathology im- 
mediately following surgical resection, Control valves were obtained from au- 
topsy. Chordal and valve sections (the free third of the leaflet) were weighed 
and digested with proteinase-K. Aliquots of the sample solutions were further 
digested using enzymes for speciiic GAGS at 37°C for at least 3 hours, then 
fluorotagged at 37°C for 16 hours. The samples were electrophoresed for 75 
minutes, and the gels imaged to quantify the specific GAG bands. GAG class 
amounts were calculated as percentages of the total GAG content. 
Results: Myxoid leaflets had proportionately 51% and 26% more chon- 
droitin/dermatan 6- and 4-sulfate (p < 0.05), respectively, and 13% less 
hyaluronan than normal leaflets (Table 1). Myxoid chordae had proportion- 
ately 47% more chondroitin/dermatan 6-sulfate (p < 0.05), 32% more hyluro- 
nan, and 27% less chondroitinidermatan 4-sulfate (p < 0.05) than normal 
chordae. 
Conclusions: These FACE results indicate that the normal population 
of GAGS is altered in the myxomatous mitral valves. Because GAGS have 
diverse structural and regulatory roles in connective tissues, the shifts in GAG 
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Table 1: Percentage content of GAG classes (mean 5 standard deviation). * p < 0.05, 
myxoid vs normal 
GAG Class Normal Mvxoid Normal Mvxoid 
HV”kkO”“” 
Leaflets 
50.3 + 6.5 
Leaflets 
44.0i7.7 
Chordae 
24.5 * 7.4 
Chbrdae 
32.3 + 8.0 
Chondroitin 
Chondroitinl 
Dermatan B-Sulfate 
Chondroitinl 
Dermatan 4.Sulfate 
Heparan Sulfate 
Keratan Sulfate 
3.8 + 2.9 1.7 f 1.2 5.5 * 2.2 3.1 zk 2.5 
16.6 f 2.9 25.0 zt 5.8' 16.6 * 4.4 24.5 * 5.1' 
19.5 A5.2 24.6 zk 5.2' 39.1 f 7.7 28.4 zk 4.0* 
5.0i4.7 0.7 IO.0 6.2 f 2.3 5.9io.2 
4.8 + 1.6 3.9 f 3.7 8.1 3~4.9 5.8f6.6 
proportions may be associated with the altered mechanics of myxomatous 
mitral valves measured previously. 
1 1070-64 1 Impact of 3-D Echocardiography in Diagnosis and 
Management of Mitral Valve Disease: 
A Prospective Surgical Validation 
Silvana MOller’, Thomas BaneI*, Elke Neubauer’ , Christph Miiller’, 
R. Erbels, 0. Pachinger’ ‘Universifies Innsbruck, Austria; “Essen, 
Germany 
Background: The aim of the study was to ascertain, whether preoperative 
3-D image reconstruction of the mitral valve apparatus can facilitate the 
diagnosis and therapeutic management in different mitral valve diseases. 
Method: In 18 patients with morphological and functional disorders of the 
mitral valve (mitral valve prolapse (MVP) n = 11, mitral valve annular dilation 
(MVAD) n = 4, postrheumatic mitral valvular leasions (PRML) n = 3) a 3-D 
data set was acquiered using transesophageal rotational scanninng at 2” 
angular intervalls. Mitral annular configuration was assessed from extractive 
3-D imaging over the heart cycle. A left atrial unroofed view and a view 
from the ventricular side of the mitral valve were reconstructed. In MVP, the 
involved scallop was identified and the prolapsing area (PA) measured. All 
subjects subsequently underwent valve surgery. 
Results: In MVP, the involvement of prolapsing scallops (PS) was visual- 
ized exactly: middle PS of the posterior leaflet n = 9, anterior PS of anterior 
leaflet n = 1. In all patients the PS was found intraoperatively as predicted by 
3-D echocardiography. The echocardiographic PA was shown to be in good 
agreement with intraoperative measurements (r = 0.79, p < 0.05). In MVAD, 
the echocardiography derived diastolic annular diameter corresponded to 
the diameter determined intraoperatively. In MVP and MVAD the unroofed 
left atrial view was found to be sufficient for evaluating valvular pathology. In 
PRML, an additional left ventricular view was mandatory for the assessment 
of the mitral valve area and the morphology of the commissures. 
Conclusions: In MVP, 3-D echocardiography gives assistence to the 
surgeon especially by providing a ‘surgical view’. This way, preoperative 
decision-making, whether the valve can be reconstructed or not and how 
reconstruction should be performed, becomes possible. 
tIl 1070 65 Outcome of Mitral Valve Prolapse: A Large 
Population-Based Study 
Jean-Francois Avierinos, Vuyisile T. Nkomo, Maurice E. Sarano. Mayo 
Clinic, Rochester. Minnesota, USA 
Background: The outcome of mitral valve prolapse (MVP) is uncertain 
because previous studies involved either referred (therefore biased) popu- 
lations or were small population based studies. Furthermore, MVP can be 
associated with variable severity of mitral regurgitation (MR) or left ventricu- 
lar dysfunction and the outcome of various subsets of patients is unknown. 
Therefore we analyzed MVP outcome in large population-based group of 
patients. 
Methods: Between 1989 and 1998, 825 residents of Olmsted County, 
MN, were diagnosed with MVP without any other valvular or congenital 
abnormality at Mayo Clinic. We analyzed the IO year survival, overall, and 
as related to clinical and echocardiographic characteristics at baseline using 
Cox proportional hazards model, and finally we compared observed mortality 
to expected. 
Results: Of the 825 patients with MVP, 81 were deceased after a mean 
follow up of 4.6 f 3.2 years. Significant univariate predictors of mortality 
were: age (p < O.OOl), higher systolic blood pressure (p = 0.023), presence 
of moderately severe or severe MR (p < O.OOl), left ventricular ejection 
fraction (LVEF, <5O%)(p < O.OOl), enlarged LV end-systolic diameter (p = 
0.03). enlarged left atrium (>50 mm) (p < 0.001). Overall survival was 82 
f 4% at 10 years and was not significantly different from expected survival 
(p = 0.26). Subgroup analysis showed that survival at 10 years was lower 
for patients with MVP with moderately severe or severe MR (60% vs 86%, 
p < O.OOl), with low EF (39% vs 87%, p < 0.001) and with enlarged LA 
(52% vs 88%, p < 0.001). The comparison of observed versus expected 
mortality showed no significant difference within. subgroups but significant 
excess mortality was observed in patients with MVP and low LVEF (p < 
0.001). 
Conclusion: In a large population based study of patients with MVP, 1) 
overall good vital prognosis was observed, but 2) some subsets of patients 
may display excess mortality which reaches statistical significance for those 
with reduced EF. These population-based data underscore the importance 
of differentiating prognosis of MVP depending on baseline characteristics at 
diagnosis. 
) 1070-66 1 The Prognostic Role of Arrhythmias in Mitral 
Valve Prolapse: Results of a Ten-Year Prospective 
Follow-up 
Alfred0 Zuppiroli, Fabio Mori, Silvia Favilli, Mauro Bini, Giorgio Cork, 
Alessio Montereggi, Gianna Galeota, Albert0 Dolara. CardiologiaZ, 
Ospedale Caregg/, Firenze, /ta/y 
Background: In patients (p) with Mitral Valve Prolapse (MVP) major com- 
plications can be predicted by some demographic, clinical and echocardio- 
graphic parameters. While palpitations are common in these p, the preva- 
lence of arrhythmias has been variously reported and their prognostic value 
still needs to be clarified. 
Methods: 104 consecutive p with MVP (diagnosed by means of strict 
M-Mode and 2D echocardiographic criteria) underwent a 24-hour Holter 
monitoring at enrollment and were prospectively followed-up for a mean of 
127 f 61 months. Mean age was 38 i 18 years,‘51 (49%) were males. 
Complex atrial (CAA) and ventricular arrhythmias (CVA) were present in 6 p 
(6%) and in 22 p (22%), respectively. 
Results: During the follow-up a total of 22 MVP-related major compli- 
cations occurred in 20 p (17: mitral surgery; 5: cardiac death) (2.0 per 100 
patient/years). Cardiac deaths were: sudden (2) due to pulmonary oedema 
(2) amd to cerebral embolism (1). At the univariate analysis overall compli- 
cations resulted significantly associated with age (p = 0.007) male gender 
(p < 0.05, OR = 3.0) presence of a moderate-to-severe mitral regurgitation 
(p = 0.002, OR -8.6), left atrial (p < 0.001) and left ventricular (p < 0.001) 
enlargement; among these variables, only left chamber anlargement resulted 
independently correlated at multiple logistic regression. Cumulated complex 
arrhythmias showed a weak correlation (p = 0.05; OR = 2.8) with overall com- 
plications: significance was higher if death only was tested (p = 0.018, OR = 
12.3). At multiple logistic regression they resulted as the unique independent 
predictor for death (p = 0.049) especially when considering CVA only (p = 
0.038). 
Conclusions: This prospective ten-year follow-up confirm the previously 
reported association between some clinical/echocardiographic parameters 
and overall complications in MVP and seems to confere to CVA a potential 
role in detecting p at risk of cardiac death. 
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9:15 a.m. 
1 831-l ] Surgery for Myxomatous Mitral Regurgitation: 
Trends Over an Eleven-Year Period 
Jenny Wu, A. Marc Gillinov, Craig R. Asher, Delos M. Cosgrove, Brian 
P. Griffin. C/eve/and Clinic Foundation, C/eve/and, OH, USA 
Background: Mitral valve (MV) repair is now the surgical treatment of choice 
for myxomatous mitral regurgitation (MR). However, given the improved sur- 
gical techniques and changing indications for surgery over the last decade, 
we hypothesized that temporal changes in demographics and MV pathol- 
ogy may have occurred among patients (pts) having surgical correction of 
myxomatous MR at our institution. 
Methods: From 1985 to 1996, 1138 pts had isolated MV repair or re- 
placement for myxomatous MR. Patient trends were studied with logistic 
regression using time as a continuous variable. Variables assessed included 
age, gender, functional class, left atrial size, left ventricular end diastolic 
and systolic dimensions, left ventricular ejection fraction (EF), MV repair, MV 
replacement, anterior, posterior, and bileaflet prolapse. 
Results: Mean age was 58 + 13 years; 65% were male. The majority 
of pts were in NYHA class II with normal EF. Prolapse involved the an- 
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tenor leaflet alone (Ii%), posterior leaflet alone (60%), and both leaflets 
(29%). Ninety-two percent of all pts had MV repair and 8% had replacement. 
Operative mortality was 0.4% (511138 pts). Over this II-year period, the 
population did not show significant change in age, gender, functional class, 
or echocardiographic parameters, The proportion of surgeries for unileaflet 
prolapse declined significantly with a concomitant increase in surgeries for 
bileaflet prolapse (OR 1.07, 95% Cl 1.02-1.11, p < 0.01). MV repairs also 
increased over the time period (OR 1.08, 95% Cl 1.01-l .15, p = 0.03) with a 
corresponding decrease in MV replacements. 
Conclusions: Over an Ii-year period, we observed that: 1) pts with 
myxomatous MR are more likely to have MV repair, 2) surgery for bileaflet 
prolapse is increasing, 3) the pt population has remained the same, and 4) 
with current surgical techniques, nearly all pts can be treated by MV repair. 
9:30 a.m. 
I 831 2 Is the Use of Complex Techniques for Mitral Valve 
Repair Justified by the Long Term Results? 
Gerald M. Lawrie, Nan Ft. Earle, Elizabeth A. Earle. The Methodist Hospital, 
Houston, Texas; Bay/or College of Medicine, Houston, TX, USA 
Background: While the majority of regurgitant mitral valves are easily re- 
paired by a single simple method, others may require multiple interventions. 
There has been concern that complex repair (repair using at least 2 methods 
in addition to annuloplasty, or repair involving both leaflets) may lead to a 
higher risk of late failure. 
Methods: From 1983-1999, 271 consecutive patients on a single ser- 
vice had mitral valve repair for mitral regurgitation. Median age was 65 
years (range 16-87), males, 49% (p = NS for complex repair vs. simple 
repair for both). Preoperative EF: 59% (range 24-88) but simple repair 
was 55% (25-85) vs. complex repair, 60% (24-88), ,(p = 0.023). Repar- 
ative techniques included ring annuloplasty, Kay annuloplasty, leaflet re- 
sectioniplication, PTFE, chordal replacement, and pericardial patch grafts. 
Bileaflet repair was done in 36 patients, (13.3%). 
Results: Complex repair was done in 97 patients (35.8%). Perioperative 
mortality, for complex repair was 3.1% (3/97); and for simple repair was 2.9% 
(5/174), (p = NS). Hospital length of stay, for a complex repair was 9.0 days 
and for a simple repair was 9.0 days (range 3-141) (p = NS). Kaplan-Meier 
estimates of survival at 5 and 10 years were for complex repair: 5 years, 
88%; 10 years, 65.6% and for simple repair were: 5 years, 71.2% and 10 
years, 52.1%, (p = 0.091). Freedom from reoperation at 5-10 years was for 
complex repair: 90.6% & 85.3% and for simple repair: 80.5% & 80.5%, (p = 
0.81). 
Conclusion: Complex repair was associated with excellent long-term 
results, at least as good as simple repair. This study suggests that almost 
all insufficient valves should be repaired by applying additional techniques if 
simple repair is not feasible. The added complexity of repair did not diminish 
its reliability in this experience. 
9:45 a.m. 
/. 831 3 A Prospective Study of Changes in the Quality of 
Lrfe of Patients Following Aortic Valve Replacement 
Ira R.A. Goldsmith, Gregory Y.H. Lip, Ramesh L. Patel. University Depf of 
Medicine, City Hospital, Birmingham & Cardiothoracic Surgical Unit, 
Walsgfave Hospital, Coventry, UK 
Background: The primary aim of aortic valve replacement (AVR) is to im- 
prove the overall functional capacity and health of patients. To assess whether 
following AVR there was an actual improvement in quality of life (QOL) of 
patients 62 consecutive patients (36 males, mean age 68 f 10) who un- 
derwent primary, AVR from April 97 to August 98 were asked to complete 
the validated short form 36 questionnaire. QOL parameters were determined 
before and 3 months after surgery prospectively. 
Results: On a scale O-l 00 mean scores showed that following AVR there 
was significant improvement in all 8 QOL parameters namely, (i) physical 
function (67 rt 26 v 0.37 & 28; p < 01) (ii) role limitation due to physical 
function (52 f 43 v 20 f 37; p < O.Oi), (iii) social function (80 i 25 v 59 & 
30; p < O.Ol), (iv) role limitation due to emotional problems (64 & 41 v 41 * 
46; p = 0.01) (v) energy (62 i 22 v 42 f 23; p < 0.01) (vi) mental health 
(78 f 19 v 63 i 22; p < O.Ol), (vii) pain (78 f 27 v 67 f 32; p = 0.02), and 
(viii) general health perception (72 f 20 v 58 i 21; p < 0.01). Moreover, (i) 
following mechanical AVR and bioprosthetic AVR there was improvement in 7 
of 8 QOL parameters; (ii) patients with AS had significant improvement in all 8 
QOL parameters whilst patients with AR showed improvement in only I QOL 
parameter; (iii) patients with valve sizes ~21 mm had improvement in 5 of 8 
QOL parameters whilst those with implant size > 23 mm had improvement 
in all 8 QOL parameters regardless of post-AVR peak gradients of ~20 or 
>20 mmHg. 
Conclusion: There was significant improvement in the QOL of patients 
3 months following AVR regardless of the type of aortic implant used and 
trans-valvular gradient. Patients with smaller implants were less likely to 
show significant improvement in all QOL parameters, patients presenting 
with AR were unlikely to show significant improvement in most of their QOL 
parameters 3 months post-AVR. 
10:00 a.m. 
El 831 4 Long Term Outcolme of Surgical Versus Medical 
Treatment in Endocarditis Complicated bv 
Perivalvular Abscess 
Kwan-Leung Chan. University of Oftawa Heart Institute, Ottawa, Canada 
Background: Perivalvular absceiss (AB) is an ominous development in pa- 
tients (pts) with endocarditis and is an indication for early surgery because it 
is generally believed that AB does not respond to medical treatment alone. 
Methods: We identified all pts with endocarditis and AB by reviewing a 
prospective registry and by a comprehensive medical audit using appropriate 
International Classification of Diseases codes. The pts were followed for a 
minimal of four years. 
Results: 35 pts were identified consisting of 13 pts with native valve 
endocarditis and 22 pts with prosthetic valve endocarditis. During hospital- 
ization 23 pts had cardiac surgery; 12 received medical treatment pts refused 
surgery and 10 were not accepted for surgery (serious concomitant condition 
in 3; prohibitive risk in 7). The medical pts were similar to the surgical pts in 
age (62 i 17 vs 52 + 15 years, p = 0.09), pts with prosthetic valves (8 vs 12), 
pts with Staph aureus infection (4 vs IO), and heart failure class (2.4 + 0.7 
vs 2.8 + 0.8, p = 0.12). In the surgical group there were 3 in-hospital deaths 
and 4 pts required repeat surgery. Three medical pts had late surgery at 7, 
11 and 16 months. The survival curves of the 2 groups were similar. 
Conclusion: In addition to an increased in-hospital morbidity and mottal- 
ity, endocarditis pts with AB have a poor long term prognosis irrespective of 
early surgical intervention, Our data suggests that medical treatment alone 
can be appropriate for some of these pts. 
lo:15 a.m. 
El 831 5 Prediction of Operative Mortality Following Valve Replacement Surgery 
Fred H. Edwards, Elizabeth R. DeLong, A. Laurie Shroyer, Kevin 
J. Anstrom, Fred L. Grover, Eric D. Peterson. For the Society of Thoracic 
Surgeons (STS), Chicago, IL and Duke Clinical Research Institute, Durham, 
NC, USA 
Background: Risk models of operative mortality (OM) for coronary bypass 
grafting (CABG) have gained wide acceptance, but to date there is limited 
information regarding risk factors for mortality following cardiac valve surgery. 
Methods: The STS National Cardiac Surgery Database was used to 
develop models of OM associated with valve replacement surgery. The study 
population was drawn from 92,536 registered patients undergoing aottic 
(AVR) or mitral valve replacemert (MVR) from 1994 through 1997. 
Results: We found considerable overlap in major risk factors for OM 
among patients receiving isolated AVR or MVR and likewise for those re- 
ceiving MVR + CABG or AVR + CABG combinations. We thus created two 
logistic models: one for the 49,073 patients who underwent isolated AVR 
or MVR and one for the 43,463 receiving a Valve + CABG combined pro- 
cedure Strongest predictors of OM in both models were emergent/salvage 
Predicted 
<2.5% 
2.5-5% 
5-l 0% 
1 O-20% 
zo-30% 
30-500~ 
>50% 
Observed 
Isolated Valve Valve + CABG 
1.6% 1.9% 
3.5% 3.7% 
6.9% 7.1% 
13.5% 13.5% 
24.1% 24.1% 
36.2% 37.8% 
62.0% 61.4% 
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procedures, recent myocardial infarction, reoperations, and renal failure. The 
table shows comparison of predicted vs. observed results for both models. 
The c-statistics were 0.766 for the isolated valve model and 0.739 for the 
combined valve + CABG model. 
Conclusion: Using the nation’s largest clinical database, we developed 
accurate models to predict operative risk in patients undergoing isolated 
valve or valve + CABG surgery. These models should setve as an important 
quality improvement tool by providing a national benchmark for valve surgery. 
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I 1093 63 Usefulness of the Indexed Effective Orifice Area to Predict Resting and Exercise Gradients in 
Biological Aortic Valve Substitutes 
Philippe Pibarot, Jean G. Dumesnil, Martin Briand, lsabelle Laforest, 
Jean Jobin, Paul Carlier. Quebec Heart Insfitufe, Quebec, Canada 
Background: An important objective of aortic valve replacement is to min- 
inuze postoperative transvalvular pressure gradients to optimize the normal- 
ization of LV mass and function. However, previous studies have shown that 
many patients with a stented aottic bioprosthesis can have relatively high 
gradients despite a normally functioning valve. The objective of this study 
was to compare the behavior of the gradients at rest and during exercise in 
different aortic valve substitutes. 
Methods: Three hundred and ninety six (396) patients (pts) were evalu- 
ated by Doppler echocardiography 1 to 3 years after aortic valve replacement 
with either a stented bioprosthesis (51 pts), a stentless bioprosthesis (194 
pts), or a pulmonary autograft (96 pts). Valve effective orifice area (EOA) and 
mean transvalvular gradient were measured at rest in all patients and during 
maximum exercise in a subgroup of 49 patients. EOA was indexed for body 
surface area. 
Results: A strong inverse exponential relation was found in all patients 
between the mean gradient at rest (r = 0.80) or during exercise (r = 0.89) and 
the resting indexed EOA. The majority (70%) of the patients with a stented 
bioprosthesis had an indexed EOA 2 0.85 cm*/m* and were therefore on 
the steep portion of the exponential curves where gradients were relatively 
high at rest (18 rt 9 mmHg) and increased markedly with exercise (25 i 11 
mmHg). In contrast, most patients (69%) with a stentless bioprosthesis and 
all patients with a pulmonary autograft had an indexed EOA > 0.85 cm’/m’ 
and were therefore on the flat portion of the curve where gradients were rela- 
tively low both at rest (stentless biop.: 7 i 5 mmHg, autograft: 2 f 2 mmHg) 
and during exercise (stentless biop.: IO f 7 mmHg, autograft: 3 i- 2 mmHg). 
Conclusion: These relations confirm that the indexed EOA, which can be 
estimated before operation, is the most powerful predictor of postoperative 
gradients both at rest and during exercise and that it should ideally be no less 
than 0.85 cm2/mz. They also show that, to reach this objective, pulmonary 
autografts or stentless bioprostheses are superior to stented bioprostheses. 
1093-64 Excellent Performance of the Freestyle Stentless 
Bioprosthesis in a Small Aortic Annulus: The 
World Wide Experience 
Leo H.B. Baur, Xu Y. Jin, Arie-Pieter Kappetein, Jean Dumesnil, 
Mark Hazekamp, Ernst E. van der Wall, Albert V.G. Bruschke, Hans 
A. Huysmans. Leiden University Medical Centre, Leiden, the Netherlands 
Introduction: Pressure gradients of most stented bioprostheses and me- 
chanical valves in aortic position are relatively high. This can be a problem 
in small aortic roots and when left ventricular function is compromised. 
Aim of the Study: To determine performance of the stentless aottic 
xenograft related to valve size within 4 weeks after implantation using three 
different techniques: Subcoronary (SC), Root-Inclusion (RI), Full Root (FR). 
Valve 
size 
(mm) 
Subcoronary 
Mean Gradient 
(mmHa) (mmHa) 
Full Root 
Mean Gradient 
Gradient 
Root Inclusion 
Mean Gradient 
(mmHal 
P-Value 
Comparison of 
three techniaues 
19 17.34 8.1 11.9i5.3 <0.003 
21 14.8 * 8.3 8.7 * 3.9 12.5 * 6.7 <O.OOi 
23 12.9 i 6.5 7:3 i 4.1 13.2 * 10.4 <O.OOl 
25 10.0z!z55.1 6.3 ;t 4.7 9.4 + 6.4 <O.OOl 
27 7.8 f 4.2 4.8 4~ 3.6 6.4 i 3.1 <O.OOi 
Methods: In 1100 pts, Doppler ultrasound examination was performed 
within 4 weeks after implantation of the Freestyle aortic xenograft. 
Results are presented in the table. 
Conclusion: The Freestyle stentless aortic bioprosthesis has very low 
gradients, even in the smaller sized valves. If used with the full root technique, 
gradients are lowest. The Freestyle is therefore very suitable in smaller aortic 
roots. 
I 1093 65 Six Year Follow-Up Results With the Toronto 
SPV@ Bioprosthetic Heart Valve 
Ivan Aleksic, Mersa M. Baryalei, Justus Strauch, Frank Reitmeier, 
Ardawan Rastan, Theodorus Tirilomis, Lars Meier’ , Harald Dalichau. Dept. 
of Thoracic and Cardiovascular Surgery; ‘Cardiology, 
GeorpAugust-University Gdttingen, Germany 
Background: A prospective study of the Toronto SPV@ bioprosthesis was 
initiated due to assumed hemodynamic superiority and longevity of stentless 
aortic bioprostheses. 
Methods: Since 3/93 186 patients received the Toronto SPV@ biopros- 
thesis for aortic valve replacement (AVR). 134 had leading stenosis, 15 aortic 
insufficiency and 37 a combined lesion. All pts were in NYHA class III-IV 
preoperatively. All patients underwent transesophageal echocardiography 
(TEE) intraoperatively before cardiopulmonary bypass (CPB). Clinical and 
echocardiographic exams were performed at 1 week, 6, 12, 24, 36 and 72 
months postoperatively. 
Results: Mean patient age at surgery was 71 * 5 years (range 29-85). 
Coronary artery disease mandating additional bypasses (CABG) was present 
in 74 pts. Mean ischemic time was 58 min (range 49-129) for simple AVE 
and 86 min (66-136 min) with AVR plus CABG. Perioperative mortality was 
low with 3.8% (7/186). Of all 31 pts after six years 21 were anticoagulated 
with acetylsalicylic acid, 2 with coumadine and 8 not at all. 
Pts after 6 vrs with Toronto valve fN = 31) 
Mean velocity (m/set) 
Mean gradient (mmHg) 
NYHA class I-11 
1.82 zk 0.61 
5.4 zt 2.3 
26/31 (64%) 
Conclusion: Mean transvalvular gradients stay low with the Toronto 
SPV@ valve. After 6 yrs no significant valve degeneration or insufficiency 
was identified. The majority of pts is in NYHA class I-II indicating persistent 
functional improvement. No tromboembolic complications were observed. 
Longer follow-up needs to determine if the Toronto SPV@ valve will outlive 
stented bioorostheses. 
I 1093 66 Increased Left Ventricular Mass Index Predicts Greater Resource Utilization and Poor Outcomes 
in Patients Undergoing Aortic Valve Replacement 
Rajendra H. Mehta, David Bruckman, Sugata Das, Thomas Tsai, 
Pamela Russman, Dean Karavite, Hiliary Monaghan, Michael Shea, Kim 
A. Eagle, G. Michael Deeb. University of Michigan Heart Care Program, 
Ann Arbor; Michigan, USA 
Backgroud: Increased left ventricular mass index (LVMI) has been shown to 
be associated with higher mortality in epidemiological studies. However, the 
impact of increased LVMI on outcomes in patients undergoing aortic valve 
replacement (AVR) is unknown. 
Methods: To assess the influence of LVMI on outcomes in patients under- 
going AVR, we studied retrospectively 473 consecutive patients (mean age 
61 yrs, males 39.7%) undergoing elective AVR. Echo data on LV dimensions 
were used to calculate LVMI by the method of Deveroux et al. LVMI was 
considered increased if > 134 mg/m* for males and > 110 mg/m’ for females. 
Results: LVMI was increased in 25% of patients undergoing AVR (male 
vs female = 22.4% vs 27.3%, p = ns). Increased LVMI was associated more 
with congestive heart failure (CHF) vs no CHF (36% vs 19%, p < O.OOi), 
and aottic plus mitral valve disease vs aortic valve disease alone (36% vs 
22%, p = 0.02). Post AVR events of respiratory failure (RF, need for ventilator 
> 72 hrs); ventricular tachycardiaffibrillation (VTNF); renal insufficiency (RI, 
increase in baseline creatinine P 2.0 mg%); length of stay in ICU [LOS, 
(mean, median)]; CHF; and in-hospital mortality were all higher in patients 
with increased LVMI (see table, * = p < 0.001). The incidence of CVAITIA 
and the need for a permanent pacemaker were similar in the two groups. 
Multivariable logistic regression analysis to account for various confounding 
variables affecting mortality, identified LVMI to be the strongest predictor of 
LVMI 
Increased 
Normal 
CHF 
8.7%’ 
1 .9% 
RF 
14.8%’ 
3.0% 
RI 
19%* 
4% 
VTNF 
13%’ 
3.6% 
LOS (days) 
7, (3)’ 
3. (2) 
Mortality 
17.4%’ 
1.4% 
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in-hospital mortality (OR 25.9, Cl 7.8-85; standardize estimate 0.77; p < valve recipients receiving long-term anticoagulation who undergo non-car- 
0.0001). diac surgery. 
Conclusions: Increased LVMI is associated with both increased resource 
utilization and poorer outcomes (including higher in-hospital mortality) in 
patients undergoing elective AVR. Further studies are needed to address 
whether AVR performed earlier, before LVMI increases, will improve out- 
comes. 
Methods: A records review identified 60 mechanical valve recipients who 
received perioperative LMWH and underwent 88 elective noncardiac proce- 
dures (47% male, 53% female, mean age 69 & 12, range 18 to 85). Warfarin 
was stopped 5 days prior to the procedure and enoxaparin administered 
twice daily by 30 mg SubCutaneOlJS injection three days preoperatively until 
the morning of the procedure. One evening dose was administered on the 
day of surgery then resumed twice daily. Warfarin was restarted the evening 
of surgery at the pre-operative dose. Enoxaparin was continued until patients 
were within their preoperative target international normalized ratio (INR). 
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/ 1114-63 1 Thrombolytic Therapy for Prosthetic Valve 
Thrombosis - Do the Long Term Results Parallel 
the Acute Gains? 
Dhiraj Gupta, Shyam S. Kothari, Jai Verma, Vinay K. Bahl, Kewal 
C. Goswami, K.K. Talwar, Subhash C. Manchanda, P. Venugopal. 
Cardiothoracic Centre, A// lndia institute of Medical Sciences, New Delhi, 
India 
Background: Thrombolytic therapy (TT) for prosthetic valve thrombosis 
(PVT) has emerged as an acceptable alternative to surgery but its suc- 
cess and complication rates are still controversial and the long term results 
are not clear. 
Methods: From 1990 through 1999, 130 consecutive episodes of left 
sided PVT (113 mitral, 16 aortic, 1 both) occurring in 110 patients (52 males, 
58 females; mean age 34.9 years) were treated with TT (Streptokinase in 
122, Urokinase in 8), according to a specified protocol of prolonged infusion. 
Serial (at least 24 hourly) echo-Doppler parameters (trans-valvular gradients 
and valve area) were monitored in all patients to guide the duration of TT and 
to quantify its efficacy. 91 of the 100 survivors of the index episode (91%) 
were followed up clinically and with echo Doppler examination for a mean 
period of 33.4 i 27.1 months (range I-110 months). 
Results: Complete success (on clinical, cineflouroscopy and echo-Doppler 
criteria) was seen in 104 (80%) episodes, partial success in 13 (10%) and 
failure in 13 (10%) including deaths in 10 (7.8%) patients. The mean duration 
of TT was 43.4 & 18.5 hours The incidence of complete success varied with 
the NYHA class at presentation (83.7% in class l/ll/lll vs 65.7% in class IV, p 
< 0.05) but not with the type or position of prosthesis. Short duration of symp- 
toms (<I5 days) and shorter time lag since surgery (~6 months) predicted 
significantly greater extent of success (decline in gradients and increase in 
valve area), p = 0.001. Besides three cases of fatal intracranial hemorrhage, 
there were 26 embolic complications (20%), including 8 major strokes. These 
were significantly more frequent in patients with NYHA class III/IV (p = 0.04) 
and in those with atrial fibrillation (AF) (p = 0.03). On follow up, there were 
25 recurrences of PVT (25% of survivors) of which 20 again received TT 
with success in 16 (80%). First and second therapies were equally effective, 
p = NS. The presence of chronic AF was the lone significant predictor of 
recurrence (p = 0.04). In patients without PVT recurrence the transvalvu- 
lar gradients and valve area did not change at the follow-up echo-Doppler 
examination. 
Conclusions: In this largest ever study of TT for PVT, and the first 
one with prospective long term follow up, we have shown that this therapy 
is associated with a high incidence of embolic complications and a very 
high recurrence rate. Lesser NYHA class at presentation, shorter duration 
of symptoms and shorter time since surgery are predictive of higher acute 
success. The alarmingly high rate of recurrence warrants a close surveillance 
for all patients, especially in patients with AF. 
Results: Of the 88 non-cardiac procedures, 27 (31%) were performed on 
patients with aortic prostheses, 50 (57%) with mitral prostheses, 9 (10%) with 
mitral and aortic prostheses and 2 (2%) with tricuspid prostheses. Among 
these patients, 50 (57%) had a history of atrial fibrillation; 23 (26%) had a 
history of thromboembolism (cerebrovascular event, peripheral thromboem- 
bolism or transient ischemic attack); 24 (27%) had a left ventricular ejection 
fraction less than or equal to 40% and 77 (88%) were older than 60 years. Dur- 
ing a three-month follow-up, none of the patients suffered an embolic event. 
Bleeding complications were experienced after three procedures (3.8%). We 
estimate the total cost of this protocol to be $185 per patient, whereas hospital 
charges for inpatient administration of heparin are $575 per day. 
Conclusions: This regimen of outpatient perioperative low-molecular- 
weight heparin provides a safe, consistent, cost-effective strategy for reduc- 
ing the thromboembolic risks of mechanical valve recipients who undergo 
non-cardiac surgery. 
L--.-L- 1114 65 Thrombo-Embolic Complications Following Surgery for Mitral Regurgitation: Need for an 
Aggressive Prevention 
Maurice E. Sarano, Hugh C. Smith. Mayo Clinic, Rochester, Minnesota, USA 
Background: Mitral Regurgitation (MR) is considered as rarely causing 
thrombo-embolic complications (TE) despite marked left atrial (LA) enlarge- 
ment. However, the rate of TE after surgical correction of MR and its deter- 
minants are unknown, hindering attempts at prevention. 
Methods: We studied the outcome of 1379 patients (age 65 f 12 years, 
61% males) who underwent surgical correction of MR between 1980 and 
1995. Preoperatively, 41% were in atrial fibrillation (AFib), 41% had associ- 
ated coronary disease (CAD), LA was 49 i IO mm and ejection fraction was 
57 & 13%. 
Results: During follow-up 213 confirmed thromboembolic complication 
occurred in 160 patients. The rate of initial thromboembolism and the total 
yearly rates are indicated below: 
B-year rate 1 o-year me Yearly rate P (with 
w CW (%/patient-year) previous row) 
Overall 1411 20*2 3.1 
Repair 911 15i2 2.2 
Replacement 19i2 29i3 4.6 0.0001 
Bioprosthesis 14zk3 23 i 4 3.1 
Mechanical P. 23zk3 3514 5.8 0.01 
The rates of thromboembolism were not related to the preoperative age, LA 
size, ejection fraction oratrial fibrillation (all P > 0.50). In multivariate analysis 
the only independent determinants of thrombo-embolism were valve repair 
(relative risk 0.47-95% confidence interval 0.36-0.69; P < 0.0001) and the 
presence of CAD (relative risk 1.62-95% confidence interval 1.17-2.24; P = 
0.004) with a trend for excess risk with a history of hypertension (P = 0.07). 
Conclusion: In patients undergoing surgical correction of MR, throm- 
boembolic complication 1) occur at relatively high rate of 3.1% per year, 2) 
are poorly related to preoperative status apart from the association to CAD, 
3) are lowest in patients undergoing valve repair, which should be aggres- 
sively pursued, but 4) are not ~2% in any subgroup justifying trials of new 
approaches for their prevention 
L-l 1114 64 Outpatient Anticoagulation Protocol for Mechanical Valve Recipients Undergoing 
Non-Cardiac Surgery 
John M. Galla, Bryan E. Fuhs. University of Washington, Seattle, 
Washington; Spokane Cardiology P.S. C., Spokane, Washington, University 
of Washington, Seattle, Washington, USA 
Background: Controversy exists over the perioperative anticoagulation of 
mechanical valve recipients during elective noncardiac surgery. Low-molec- 
ular-weight heparin (LMWH) has become an alternative to traditional meth- 
ods without data to support its use. This study evaluated the efficacy of 
an outpatient regimen of perioperative LMWH, enoxaparin, for mechanical 
L-2 1114 66 Risks and Benefits of Adding Anti-Platelet Agents to Warfarin Among Patients With Prosthetic Heart 
Valves: A Meta-analysis 
Stephen H. Little, David R. Massel. The Department of Medicine, University 
of Western Ontario, London, Canada 
Background: We report a mete-analysis of all available, methodologically 
sound data to further assess the safety and efficacy of combined oral an 
ticoagulant and antiplatelet therapy versus anticoagulant monotherapy in 
patients with prosthetic heart valves. 
Methods: Medline and manual searches of review, consensus and indi- 
vidual reports published or described in abstract in any language from 1966 
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to January 1999. Inclusion criteria were randomized controlled clinical trials 
comparing combined antiplatelet agent with oral anticoagulant against oral 
anticoagulant alone. 
Results: Eight prospective, randomised controlled trials met inclusion 
criteria. Study endpoints were thromboembolic event, mortality or major 
bleeding. Overall, the addition of antiplatelet agents reduced the risk of 
thromboembolic eventswith a typical odds ratio of 0.38 (95% Cl: 0.26 to 0.56, 
p < 0.001). The heterogeneity chi-square was not significant; p = 0.68. This 
treatment effect corresponds to a relative risk reduction (RRR) of 61% (95% 
Cl: 40 to 74%) and a number needed to treat (NNT) of 29 (95% Cl: 19 to 66). 
To&l mortality with antiplatelet agents was reduced with an odds ratio of 0.46 
(95% Cl: 0.32 to 0.66, p < 0.001). There was no evidence for heterogeneity 
between studies (p = 0.49). Both aspirin and dipyridamole reduced mortality 
similarly. The overall effect on mortality corresponds to a RRR of 49% (95% 
Cl: 34 to 70%) and a NNT of 20 (95% Cl: 14 to 36). There was an increase 
in the risk of major bleeding when antiplatelet agents were added to watfarin 
therapy with a typical odds ratio of 1.48 (95% Cl: 0.99-2.21), although this 
difference did not quite reach conventional statistical significance (p = 0.056). 
The tests for heterogeneity comparing the two later aspirin trials with either 
the early aspirin or the early dipyridamole trials were marginally statistically 
significant (p = 0.066 and 0.051, respectively), suggesting that the risk of 
bleeding was less in the two most recent studies. Sensitivity analysis did not 
demonstrate a statistically significant change in any of the above endpoints. 
Conclusion: For patients with prosthetic heart valves, the addition of an 
antiplatelet agent to standard warfarin therapy confers a significant benefit 
in total mortality and risk of thromboembolism. The risk of major bleeding 
is increased with combination therapy. Nonetheless, the risk of bleeding 
appears to have diminished with the lower doses of aspirin used in the more 
recent trials, resulting in a favourable risk-to-benefit profile. 
ORAL 
18051 Aortic Stenosis: High Risk, Sudden Death, 
Valve Replacement 
Tuesday, March 14,2000, 8:30 a.m.-l 0:OO a.m. 
Hilton Anaheim, California B 
8:45 a.m. 
I 805 2 Sudden Death in Severe Aortic Stenosis 
M. Razavi, ME. Sarano, W.D. Edwards, K.R. Bailey, A.J. Tajik, R.L. Frye. 
Mayo C/ink, Rochesfer, Minnesota, USA 
Background: Sudden cardiac death (SCD) complicating severe aortic steno- 
sis (AS) has been poorly described despite the dire consequences of this 
complication. In particular, autopsy studies of patients (pts) with SCD and AS 
are lacking. 
Methods: All pts whose necropsy report diagnosed them with AS and 
SCD in our institution between 1966 and 1998 were included. Exclusion 
criteria included less than severe AS, aottic valve surgery, idiopathic hyper- 
trophic cardiomyopathy, and age < 85. Clinical data was reviewed and gross 
specimens were re-examined. 
Results: Of 186 pts in the initial group, 46 did not meet any exclusion 
criteria and were included in the study. 37 of these had AS as their immediate 
and only cause of death. In 18 (48%) of these pts had neither myocardial 
scar, coronary artery thrombus, nor any evidence of myocardial necrosis and 
AS was the only possible cause of SCD. Of the 37, 22 had antemortem 
diagnoses. 8 of these were observed. The remainder either refused (2), 
were waiting for (3), or were turned down for surgery (1). One case was 
undetermined. 18 (48%) pts did not report any symptoms at their last exam. 
Five of these pts had been examined within 3 months of SCD. 
Conclusions: We conclude that 1) SCD is a complication of severe AS 
and may occur in the absence of any other underlying cardiac pathology, 2) 
lack of appropriate diagnosis is a clinical circumstance associated with SCD 
in symptomatic pts, but 3) SCD may occur in pts with severe AS who report 
no symptoms at their last exam. The rate of SCD in severe AS should be de- 
termined and may have major implications for the management of these pts. 
9:00 a.m. 
El 805 3 Impact of the Presence and Degree of Aortic 
Stenosis on Survival in 2265 Patients With LV 
Dysfunction 
Jatin Amin, Sriram Padmanabhan, Helme Silvet, Ramdas G. Pai. Loma 
Linda VA Medical Ck, Loma Linda, CA, USA 
Calcific aortic stenosis (AS) is associated with conventional cardiac risk 
factors. Hence, we hypothesized that the presence of any degree of AS may 
be associated with higher mortality in patients with LV dysfunction. This was 
investigated in a large cohort of patients (n = 2265) with LV ejection fraction 
(EF) ( 40%. Mean age was 68 i 11 years, mean follow up of 855 days, and 
there were 743 deaths. AS was categorized into mild, moderate and severe 
grades based on continuity equation valve area. EF was visually quantified 
by a level Ill trained echocardiographer. Survival analysis was performed 
using Kaplan-Meier product limit method and the effects of covariates was 
assessed by the log rank test. 
Results: AS was present in 178 (8%) of the patients, mild in 100 (4%), 
moderate in 52 (2%) and severe in 34 (2%) patients. Presence of any AS 
was associated with a higher 5 year mortality (76% vs 60%, p = 0.03). The 
mortality increased with higher grades of AS (p = 0.04). Effect of AS on 
mortality was greater in older patients. Patients aged 265 years with AS had 
a 5 year cumulative hazard of death of 95% compared to 40% for aged 565 
and no AS (p = 0.05). Effect of AS on mortality seemed to be more marked 
in those in sinus rhythm compared to those in atrial fibrillation. 
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Conclusions: (1) Presence of AS is a strong predictor of mortality in 
those with moderate and severe LV dysfunction. (2) The impact was greater 
with greater severity of AS and in older individuals. 
9:15 a.m. 
/ 805 4 Elective Surgery in Patients With Hemodynamically Severe But Asymptomatic Aortic Stenosis? - 
Selection of High Risk Patients by Echocardiography 
Raphael Rosenhek, Thomas Binder, Gerold Porenta, Irene Lang, 
Gijnther Christ, Gerald Maurer, Helmut Baumgartner. Department of 
Cardiology University of Vienna, Austria 
We have recently shown that the extent of valve calcification is an important 
predictor of outcome in patients with hemodynamically severe but asymp- 
tomatic aottic stenosis (AS). We have also found that patients who died 
or required aortic valve replacement (AVR) because they developed symp- 
toms had a significantly faster rate of hemodynamic progression. To evaluate 
whether echocardiographic assessment of valve calcification in combination 
with serial measurements of aortic jet velocity may be helpful for the selection 
of high risk patients in whom elective surgery might be advisable, 106 initially 
asymptomatic patients with severe AS were followed for 27 * 17 months (48 
females; age 57 & 19 yrs, peak aortic jet velocity 4.5 * 0.6 m/s). Kaplan 
Meier event-free survival, with endpoints defined as death (n = 8) or AVR 
indicated by the development of symptoms (n = 59), was 67 f 5% at 1 
year, 56 f 5% at 2 years and 33 f 5% at 4 years for the entire population. 
Patients with moderate or severe valve calcification had a signicantly worse 
outcome than those with no or mild calcification with an event-free survival 
of 60 f 6% at 1 year, 47 i 6% at 2 years and 20 f 5% at 4 years vs. 92 
Z!Y 5%, 84 f 8% and 75 f 9% (p < 0.0005). By multivariate analyisis, the 
rate of hemodynamic progression turned out to be a significant predictor of 
outcome independent of the extent of calcification (p < 0.0001). The con- 
sideration of both variables together allowed the identification of a subgroup 
with extremely poor outcome: whenever an increase of 0.3 m/s or more was 
observed from one visit to the other (interval 6 to 12 months) in patients with 
moderately or severely calcified valves (n = 34), 80% died or required AVR 
within 2 years. The event-free sutvival rate for this patient-group was 64 f 
8%, 20 + 7% and 16 + 6% at 1, 2 and 4 years, respectively. 
Thus, in asymptomatic severe AS, the combination of moderate to severe 
valve calcification with rapid increase in aortic jet velocity defines a patient 
subgroup with very poor outcome in which it might be worthwhile to consider 
elective surgery. 
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/ 805 5 Outcome of Aortic Valve Replacement in Patients With Severe Aortic Stenosis Without Sianificant 
Coronary Artery Disease and Severely Depressed 
Left Ventricular Function 
Horatio Casabe, Pablo Stutzbach, Eduardo Guevara, Carmen Gomez, 
Alejandro Machain, Mariano Favaloro, Eduardo Dulbecco, Victor Caramutti, 
Ernest0 Weinschelbaum, Roberto Favaloro. Department of Surgery, 
ICYCC, Favaloro Foundation, Buenos Aires, Argentina 
Background: Previous studies of aortic valve stenosis (AVS) in patients (pts) 
with aortic stenosis (AS) and severely depressed left ventricular function 
included pts with significant coronary, artery disease (CAD), as a result the 
conclusions drawn are limited. Thus we reviewed patients with EF 4 30% 
without significant CAD who underwent AVR between 1990-I 999, to evaluate 
surgical results and predictors of left ventricular function improvement. 
Methods and Results: We reviewed 19 pts(l8 M/l F), mean age 42 i 
28 years. Ail patients had dyspnea and 11 pts (58%) were severely symp- 
tomatic (NYHA Ill or IV). Preoperative data include: EF 21.4 f 5.8% (range 
12-30%) Peak systolic pressure gradient (PSG) 55 f 24 mmHg (range 
24-100 mmHg), aortic mean pressure gradient (MPG) 37 * 16 mmHg (range 
18-60) and aortic valve area (AVA) 0.5 * 0.4 cm2 (range 0.3-0.8 cm’) The 
relationship between preoperative EF, PSG, MPG and AVA was done with 
regression lineal test. Hospital mortality was 5.2% (i/19) and follow-up sur- 
vival was 100%. Three months after surgery, all patients improved symptoms 
and EF (39 * 9.3, p = 0.0003). This improvement correlated directly with 
PSG (p = 0.0007, r = 0.56) and MPG (p = 0.0003, r = 0.61). In patients with 
lower gradients the EF improvement was lower and slower. 
Conclusion: 1) Pts with AS without significant CAD and reduced EF have 
low hospital mortality. 2) All survivors had symptomatic improvement. 3) The 
degree of EF improvement correlated directly with preoperative pressure 
gradients. 4) Based on this experience we conclude that pts with AS without 
significant CAD and reduced EF should not denied AVR no matter how low 
pressure gradients are. 
9:45 a.m. 
/ 805 6 Long Term Survival After Aortic Valve Replacement in Patients With Low Gradient Severe Aortic 
Stenosis and Significant Left Ventricular 
Dysfunction 
Jeremy J. Pereira, Craig R. Asher, Eugene H. Blackstone, lmran Afridi. The 
C/eve/and Clinic Foundation, C/eve/and, Ohio, USA 
Background: Aortic valve replacement (AVR) for patients with severely re- 
duced aortic valve area (AVA), but low transvalvular gradients in the presence 
of left ventricular dysfunction, remains controversial. Previous reports of AVR 
in this high-risk group show high short and long-term mortality. 
Methods: We identified 63 consecutive patients from our echocardiogra- 
phy laboratory database with AVA 5 0.75 cm*, mean gradient 5 30 mmHg 
and left ventricular ejection fraction (LVEF) 5 35%, who underwent AVR be- 
tween 1990 to 1998. Clinical and echocardiographic variables were analyzed 
and patients were followed for a mean of 2.8 years. 
Results: The study group included: 52 males/l1 females, mean age = 
70 & 9 years, 47.6% with prior myocardial infarction and 30.1% with prior 
coronary bypass surgery. Echocardiographic factors included; LVEF = 21 & 
7%, AVA = 0.62 i 0.11 cm*, peak/mean gradients = 42 f 7 and 25 i 11 
mmHg, respectively. In-hospital mortality was 4.8%. Kaplan-Meier analysis 
is shown with a 1 year survival = 85% and 5 year survival = 64%. Only age 
predicted long-term mortality, relative risk = 1 .I (95% Cl 1.04-l .55, p = 0.01). 
“is 
Conclusion: 1) Aortic valve replacement in patients with severe aortic 
stenosis and low transvalvular gradients can be performed with acceptable 
in hospital mortality and is associated with favorable 1 year survival following 
surgery. 2) Resting echocardiographic variables do not predict outcome. 3) 
Despite a high-risk clinical profile only advanced age predicts poor survival. 
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1160-53 Progression of Aortic Stenosis in Hemodialysis 
Craig A. Snyder, Richard H. Smith, Steven Fishbane, John Maesaka, Jason 
M. Lazar. Winthrop-University Hospital, Mineola, NY USA 
Background: Aorticvalve thickening and calcification are common echo find- 
ings in patients with end stage renal disease (ESRD). The rate of progression 
of aortic stenosis (AS) has not been well studied in this pt population. The 
objective of this study was to determine the rate of progression of AS in pts 
on hemodialysis. 
Methods: We evaluated 25 ESRD pts (15 males, 40 * 10 years) who 
underwent serial Doppler echocardiographic studies at least 5 months apart 
and had peak aortic velocity of >2.5 misec on the index study. LV dimensions, 
mass, EF, transmitral flow, peak and mean aortic valve gradients were mea- 
sured, and aortic valve areas (AVA) were calculated by continuity equation. 
Mean changes were adjusted to assess progression over one year. 
Results: 
Pararlleter 
Peak velocitv (m/s) 
Peak grad&t‘(& Hg) 
Mean gradient (mm Hg) 
Valve (cm’) area, 
Ejection Fraction (%) 
E/A ratio 
LV mass (a) 
Change/yr P 
0.47i 0.52 <O.OOi 
14.3 i 16.1 <O.OOi 
8.3i11.9 <O.OOl 
-0.23 + 0.36 <O.OOl 
-2.5 * 17 NS 
0.27 5 77 NS 
-9.0 f 120 NS 
The mean rate of decline of AVA as shown on the table above was 
independent of changes in mitral annular calcification, LV mass, systolic or 
diastolic function. Progression of AS was greater than previously reported 
values in non-dialysis pts and was most significant in males (p < 0.05). 
Conclusion: AS may progress more rapidly in ESRD pts on hemodialysis 
than previously reported in the glsneral population. In pts with end stage 
renal disease, AS may progress without significant changes in LV mass LV 
systolic function and indices of diastolic filling. These findings suggest the 
pathophysiology of AS may be different in this pt population. 
1 1160-54 1 African Americans Develop Greater Wall Mass in 
Response to Aortic Stenosis 
Thomas D. Stamos, Alexander Neumann, Chima Nwaukwa. Cook County 
Hospital/Rush Medical College, Chicago, IL, USA 
Background: Age and sex have been shown to influence left ventricular (LV) 
remodeling in patients with aortic stenosis The current study evaluates the 
influence of race on the remodeling process. 
Methods: 22 consecutive African American patients presenting to the 
echo lab with aortic stenosis were compared to age and sex matched Cau- 
casian patients with aortic stenosis. Patients with a history of coronary artery 
disease or significant coronary stenosis by angiography were excluded. Echo 
was reviewed to determine aortic valve area, LVEF, LV mass index, mean 
transaortic pressure gradient and peak LV pressure (systolic blood pressure 
+ peak transaortic pressure gradient). 
Results: African American and Caucasian patients showed no significant 
difference in age (74.5 f 14.3 yrs vs 76.1 f 13.8 yrs, p = 0.74) or peak 
LV pressure (see table) with an identical gender mix (8 male, 14 female). 
Aortic valve area was smaller and mean transaortic gradient was greater for 
Caucasians while LV mass index was greater for African Americans. 
AV Area 
W+) 
Mean Transaortic 
Pressure (mmHg) 
Peak LV 
PresstIre 
LV Mass 
(s/m*) 
WmHs) 
Caucasian 1.05 * 0.25 31.5 + 13.9 186 + 33.7 114.8131.4 
African 
American 
o-value 
1.3 + 0.40 20.2 i 13.8 174.4 i 39.2 131.1 534.6 
0.016 0.011 0.13 0.05 
Conclusions: Significant racial differences exist in LV remodeling in aortic 
stenosis, with African American patients demonstrating a greater wall mass 
in response to a similar peak LV pressure. 
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1 1160-55 1 Repeat Aortic Valve Replacement for Isolated 
Patient-Prosthesis Mismatch Associated With an 
Excellent Short-Term Survival 
Steven E. Girard, Fletcher A. Miller Jr., Willam D. Edwards, Henry 
D. Tazelaar, Douglas W. Mahoney, Youssef F. Malouf, A.J. Tajik. Mayo 
Clinic, Rochester, Minnesota, USA 
Background: Aortic valve replacement (AVR) complicated by patient-pros- 
thesis mismatch (P-PM) presents a difficult dilemma to the clinician, as the 
risk of repeat surgery must be weighed against the risk of continued left 
ventricular (LV) outlet obstruction. There is scant literature regarding repeat 
AVR surgery for P-PM. 
Methods: 20 consecutive patients (pts.) who underwent repeat AVR for 
a clinical diagnosis of P-PM between 1989 and 1998 were identified from a 
prospective surgical pathology database. Explanted valves were tilting disk 
(n = II), bileaflet (n = 4) ball-cage (n = 2), and bioprosthetic valves (n = 3), 
the average size 21 f 2 mm. We compared 12 pts. who underwent repeat 
AVR for isolated P-PM (Group A) to 8 pts who required repeat AVR for 
P-PM and any of the following: coronary bypass grafting (n = 3), mitral valve 
replacement (MVR) (n = 3), repeat MVR (n = 2), or tricuspid annuloplasty (n 
= 3) (Group B). 
Results: Clinical parameters and echocardiographic data are shown in 
the Table. The in-hospital mortality was O/12 (0%) in Group A and 5/8 (63%) 
in Group B (P = 0.004). Short-term survival at a mean follow-up of 22 months 
remained 100% in Group A patients. 
isolated Mismatch: Yes (A) No 6% 
In = 12) h=8) 
Age (Y=) 47118 61 19 
Male-n (%) 8 v33) 3 (36) 
Body surface area (m2) 1.9 ho.2 1.9 It 0.3 
Functional class Ill-IV-n (%) 4 (33) 6 (75) 
>I prior cardiac surgery-n (%) 3(13) 5 (62) 
Rheumatic disease-n (%) 3 (13) 6 (75) 
Mean AVR AP (mmHg) 46113 40*15 
Indexed AVR area (cm’lm’) 0.5 f 0.1 0.5 * 0.2 
LV ejection fraction (%) 64f17 61 zt 13 
‘P 5 0.05 using Fisher’s exact test or t-test; mean -+ SD. 
Conclusion: In-hospital and short-term survival after repeat AVR for 
isolated patient-prosthesis mismatch is excellent. Conversely, patients with 
high valve gradients secondary to patient-prosthesis mismatch who require 
AVR and concomitant major cardiac surgery are at increased risk-many 
have end-stage valvular heart disease. Functional status and the extent of 
valvular disease appear to be more predictive of outcome than prosthetic 
hemodynamic variables. 
LITI 1160 56 Subvalvular Stenosis at Repeat Aortic Valve 
Replacement for Patient-Prosthesis Mismatch 
Steven E. Girard, Fletcher A. Miller Jr., William D. Edwards, Henry 
D. Tazelaar, Douglas W. Mahoney, Youssef F. Malouf, A.J. Tajik. Mayo 
Clinic, Rochester, Minnesota, USA 
Background: Aortic valve replacement (AVR) complicated by patient-pros- 
thesis mismatch (P-PM) may necessitate reoperation. We investigated whether 
subvalvular stenosis could mimic or exacerbate left ventricular outflow ob- 
struction in patients with presumed P-PM. 
Methods: We analyzed the records of 20 consecutive patients (pts.) who 
underwent AVR for a clinical diagnosis of P-PM between 1989 and 1998. This 
cohort was identified from a prospective pathology database. The explanted 
aortic prostheses included tilting disk (n = II), bileaflet (n = 4), ball-cage 
(n = 2), and bioprosthetic valves (n = 3). Subvalvular stenosis warranting 
myectomy/myotomy was diagnosed by surgical inspection in 6 (30%). Using 
the Fisher’s exact test or an unpaired t-test, we compared the 14 pts. without 
subvalvular stenosis at repeat AVR to 6 pts. who had this diagnosed. 
Subvalvular Stenosis: 
Age (Y@ 
Male-n (%) 
Prior repeat AVR-n (%) 
NYHA class Ill or IV-n (%) 
Absent (n = 14) 
54f18 
8 (57) 
2 (14) 
6 (43) 
LV EF (%)* 58+ 16 
AVR size (mm) 20.7 * 2 
AVR mean AP (mmHg) 43+14 
AVR area (cm”/m’) 0.46 + 0.2 
Concomitant CABG-n (%) 3 (21) 
Concomitant MVRTVA-n (%) 5 (36) 
Post-op mean AP (mmHg)’ 1555 
Hospital mortality-n (%) 4 (29) 
‘P 5 0.05; continuous variables are given as mean i SD. 
Present (n = 6) 
50f15 
3 (50) 
1 (16) 
4 (66) 
73 * 4 
20.6 f 2 
45% 14 
0.60 + 0.1 
0 (0) 
2 (33) 
20f4 
1 (17) 
Results: Echocardiographic and clinical variables are shown in the Table. 
Transthoracic echocardiography (TTE) suggested subvalvular stenosis in 2/6 
pts. (33%) and transesophageal echocardiography (TEE) was diagnostic in 
3/3 pts. (100%). The specificity of TTE was 92% (n = 14), TEE 100% (n = 8). 
Conclusion: Subvalvular stenosis, secondary to basal septal hypertro- 
phy, is an important cause of persistent elevated valve gradients after AVR. 
This may exacerbate or mimic P-PM. TEE is a promising tool to diagnose 
subvalvular stenosis in the setting of AVR with increased gradient. 
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L-.-i-J 1182 63 Myocardial Fibrosis in Aortic Regurgitation is a Primary Phenomenon: Artificially Stretched 
Fibroblast Biology Mimics In Viva Observations 
Edmund M. Herrold, Jeffrey S. Borer, Sharada L. Truter, John N. Carter, 
Frank Liu, Themy F. Dumlao, Jr.. Come// Universit)5 New York, NY!, USA 
Background: We have previously shown that exuberant fibrosis precedes 
and contributes to heart failure (CHF) in experimental aortic regurgitation 
(AR). AR fibrosis comprises abnormally glucosamine-rich extracellular matrix 
(ECM); fibroblast gene expression in AR is altered to promote the production 
of non-collagen ECM, specifically including hyperexpression of fibronectin. 
However, it is unclear whether these alterations are primary fibroblast re- 
sponses to volume overload or result secondarily from myocyte damage. 
Method: We isolated cardiac fibroblasts from normal NZW rabbits (the 
controls for our instrumented NZW-AR model) and assessed cell growth rate, 
incorporation of 3H-glucosamine and 3H-proline and fibronectin production 
during 4 days of cell culture in the presence and absence of externally 
applied periodic (60 cycles/min) strain that deformed cells maximally by 
IO-25% stretch, selected to model the mechanical stresses of AR. In 2 
separate experiments repeated 2x each, cells were divided into stretched 
and unstretched cultures. 3H substrate incorporation was determined by 
TCA precipitation of the ECM plus cell layer, fibronectin production by gelatin 
affinity chromatography and cell growth rate by counting. 
Results: Consistent with our earlier in vivo studies, in stretched vs un- 
stretched cells, 3H-glucosamine incorporation increased (1 vs 3.5 cpm/mg 
protein), 3H-proline incorporation decreased (1 vs 0.7 cpm/mg protein), and 
fibronectin production doubled. Ceil growth rate in culture increased 1.8 fold 
(stretched/unstretched). 
Conclusions: Even when applied during a relatively short interval, me- 
chanical stresses of AR cause isolated cardiac fibroblasts to reproduce the 
substrate uptake and ECM production characteristics of AR, suggesting that 
fibrosis in AR is a primary response to volume loading. The capacity to model 
AR fibroblast biology in vitro may facilitate identification of countermeasures 
to retard CHF development in volume overload. 
!-.--IA 1182 64 The Relationship Between Severity of Mitral Annular Calcification and Aortic Stenosis 
Frank E. Silvestry, Melissa McKernan, Martin G. Keane, Susan E. Wiegers, 
Ahsan Chowdhury, Ted Plappert, Martin St John Sutton. Cardiovascular 
Division, University of PA Health Sysfem, Philadelphia, PA, USA 
Introduction: Mitral annular calcification (MAC) is a non-inflammatory, chronic 
degenerative process. Conditions that increase mitral valve stress may ac- 
celerate these degenerative changes. Aortic stenosis (AS) is associated with 
left ventricular (LV) pressure overload, and therefore may predispose to MAC. 
Prior studies have found MAC in up to 25% of those with severe AS. To deter- 
mine the relationship between the severity of MAC and the severity of AS, we 
screened 24,071 patients (age 56 f 17; 53% F) who had echocardiograms 
performed between 1995-1999. MAC and AS were graded as absent, mild, 
moderate, and severe. Severe AS was defined as an aortic valve area i 0.7 
cm* by the continuity equation. 
Results: MAC was present in 3,475 pts (14.4%). AS was present in 845 
pts (3.5%). The prevalence of MAC in those without AS was 12.8% (3072 
pts). The prevalence of MAC in those with AS was 47.7% (403 pts). The 
prevalence of MAC increased with increasing severity of AS (36.7% mild AS; 
44.6% moderate AS; 59.0% severe AS: p < 0.001). In the 403 pts with both 
AS and MAC, we found a direct relationship between severity of MAC and 
the prevalence of severe AS (p < 0.001): 
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Conclusions: A strong association exists between the echocardiographic 
prevalence of MAC and degree of AS An increasing prevalence of severe 
AS was seen with increasing severity of MAC. This relationship may result 
from increased mitral annular stress due to LV pressure overload caused by 
AS, as well as from factors that promote calcification of both valves. 
L-2 1182 65 Planimetry of Aortic Valve Stenosis Area Using Transthoracic Two-Dimensional 
Echocardiography Associated With the Harmonic 
Imaging Technique 
S. Imbert, P. Laffort, J.N. Labeque, S. Laffite, P. Coste, C. Ja’is, R. Roudaut. 
Cardiological Hospital, Pessac, France 
Background: Planimetry of aortic valve area (AVA) using the two-dimen- 
sional transoesophageal echocardiography (TEE) has been shown as an 
accurate method for AVA measurement in patients with aortic stenosis. Re- 
cently, direct planimetry of AVA using transthoracic two-dimensional echo- 
cardiography (TTE) has been reported as a feasible method for AVA mea- 
surement in the same patients. Recent advances in TTE images resolution 
by using harmonic imaging techniques provided substantial image quality 
improvement allowing a direct visualization of the aortic valve orifice. Conse- 
quently, we sought to assess this new technique for AVA planimetry in patients 
with aortic stenosis and to compare it with standard methods of planimetry. 
Methods: 50 consecutive patients known for valvular calcific aortic steno- 
sis undervent TTE with parasternal short-axis view by two independant 
blinded observers. AVA was quantified by planimetry using harmonic imaging 
techniques for the leaflet inner edges at the time of maximal opening in early 
systole. Results were compared with AVA determined by using 1) cardiac 
catheterisation (Gorlin’s formula), 2) the continuity equation, 3). 
Results: The TTE image quality was suitable for planimety in 48 patients. 
(96%). We found a very high correlation between aortic areas calculated 
by TTE planimetry and by the Gorlin’s formula (r = 0.84, p < 0.001). AVA 
quantified by TTE planimetry was strongly correlated with the continuity 
equation (r = 0.85, p < 0.001). In addition, there was a highly significant 
correlation between TEE and TTE planimetry (r = 0.98, p < 0.001). The 
sensitivity and specificity of the TTE method for identification of severe aortic 
stenosis (~0.75 cm’) were 82% and 83% respectively. 
Conclusion: TTE planimetry coupled with harmonic imaging should be 
considered as a new quite feasible and accurate method for a reliable as- 
sessment of the aortic stenosis. 
1182-66 Planimetry of the Aortic Valve by Transthoracic 
Echocardiography is a Feasible and Reproducible 
Method for Assessing the Severity of Aortic 
Stenosis 
Andrea V. Brasch, Huai Luo, Steven S. Khan, Michele A. DeRobenis, Robert 
J. Siegel. Cedars-Sinai Medical Center, Los Angeles, California, USA 
Background: Planimetry (PLAN) of the aortic valve (AV) on transesophageal 
echocardiography (echo) is accurate, however there is little data on use of 
transthoracic echo (TTE) for determining AV area by PLAN. The purpose of 
our study is to examine the feasibility and reproducibility of PLAN of the AV 
on TTE. 
Methods: We performed PLAN of the AV on TTE in 24 patients (pts) who 
had peak AV gradient ? 20 mmHg. Each valve was planimetered 3 times 
by 2 observers with fundamental and tissue harmonic imaging. The quality 
of the images was graded as: poor, fair, good, excellent, or measurement 
not feasible. We correlated the PLAN AV areas (AVA) by fundamental and 
harmonic imaging with the AVA assessed by the continuity-equation. 
Results (see figure): PLAN was not feasible in 6 cases (25%). Image 
quality was poor or fair in 4 (17%) while 14 (58%) had good to excellent 
quality images. Interobserver agreement was over 90%. 
Conclusion: When image quality is adequate, PLAN of aortic valve 
area with either fundamental or harmonic TTE imaging is highly accurate 
and reproducible. PLAN offers an alternative to the continuity equation for 
measurement of AVA. 
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893-l Temporal Variations in Effective Orifice Area During 
Eiection: Relationship to Hemodynamic Severity in 
Patients With Valvular Aortic Stenosis 
Luc M. Beauchesne, Kwan L. Chan, Ian G, Burwash. University of Ottawa 
Heart Institute, Ottawa, Canada 
Aortic valve area is the standard index for assessing aortic stenosis (AS) 
severity. However, valve area varies during ejection and a single measure- 
ment during ejection may not adequately describe the hemodynamic burden 
imposed by a stenotic valve. We investigated whether the dynamic change 
in effective orifice area (EOA) during ejection differs between patients with 
severe AS (ASsav) [n = 151 and age/gender matched controls [n = 151 and 
whether the dynamic ejection pattern varies with AS severity [n = 451. EOA 
was measured at 1% time intervals during the ejection period from Doppler- 
echo LV outflow tract (V,,) and transvalvular (Vns) velocities. 
Results: Peak VLvoT and VAs velocity occur later in the ejection period 
in ASssv pts compared to controls (V~vor 47 f 8 vs 29 i. 8%, p < 0.001; 
VAS 36 ?I 7% vs 27 f 8%, p < 0.005). Peak VLVoT and peak VAT velocity 
occur simultaneously in controls (29 f 8% vs 27 f 8%, p = NS), however 
in ASssv pts peak VLvoT occurs later than peak VAs (47 & 8% vs 36 f 7%, 
p .Z 0.0005). ASsav pts have a slower absolute EOA opening rate (4 f 1 
vs 41 rt 38 ems/s, p < 0.005) and achieve 80% and 100% of peak EOA 
later in the ejection period (43 I 26% vs 15 + 6%, p < 0.001; 70 f 20% 
vs 48 i 30%, p < 0.05). Between1 IO and 90% of the ejection period, EOA 
tends to increase in ASsEv pts but plateaus in controls (slope 0.38 i 0.26 vs 
0.02 + 0.25% change in EOA per 1% change of ejection period, p < 0.001). 
ASssv pts spend less time during the ejection period ~80% of peak EOA (49 
f 25% vs 64 f 14%, p x 0.05). Time to peak VLVoT velocity, time to peak 
VAS velocity, time to 80% of peak IEOA and EOA opening rate correlate with 
mean pressure gradient (r = 0.63, 0.42, 0.54 and -0.80. respectively). 
Conclusion: The Doppler-echo VLvoT profile, VAs profile and dynamic 
EOA ejection pattern differ between AS pts and controls and relate to AS 
severity. Indices of ejection dynamics may provide additional information on 
the hemodynamic or physiologic severity of a given stenotic aortic valve. 
4:15 p.m. 
893-2 The Valve Resistance is Much More Flow Dependent 
Than the Valve Effective Orifice Area 
Claudia Blais, Philippe Pibarot, Damien Garcia, Danmin Chen, 
Louis-Gilles Durand, Jean G. Dumesnil. Quebec Heart Institute, Quebec, 
and Clinical Research institute of ,Montrea/, Montreal, Quebec, Canada 
Background: Aorlic valve resistance (RES) (gradient divided by flow) has 
been proposed to represent the severity of aortic stenosis because it ap- 
peared to be less affected by change in flow when compared with valve 
effective orifice area (EOA). However, this issue remains controversial. The 
objective of this study was to assess the flow dependence of these param- 
eters, first in an in vitro model and second in patients with a native or a 
prosthetic aortic valve. 
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Methods: An in vitro model was designed to measure EOA and RES by 
Doppler-echocardiography in 2 fixed stenoses, 2 bioprosthetic valves, and 
2 mechanical valves for different flow rates. RES was calculated using the 
formula: 1.33 x mean gradient/Q, where Q is the flow rate = stroke volume 
divided by ejection period. EOA and RES were also measured by Doppler- 
echo in 48 patients with either a bioprosthetic, mechanical, or stenotic native 
valve at rest and during exercise or dobutamine infusion. 
Results: 1. In fixed stenoses or in mechanical valves, RES increased 
markedly with flow rate both (n vitro (+I03 * 34% per 100 ml/s of flow 
increase) and in vivo (+I00 f 45% per 100 ml/s), whereas valve EOA 
did not change (+I i 2% per 100 ml/s). 2. In the context of a flexible orifice 
(bioprosthetic valves and some patients with a stenotic valve), EOA increased 
moderately (+9 z!= 6% per 100 ml/s) whereas was changes in RES varied 
from a moderate increase to no change (+24 f 22% per 100 ml/s). A strong 
relationship was found both in vitro (r = 0.99) and in viva (r = 0.98) between 
RES, EOA and flow rate: RES = 0.73 x (Q/EOA*). 
Conclusions: Thus, both from a theoretical and a practical standpoint, 
RES is much more flow dependent than EOA, particularly in fixed stenoses. 
Situations where RES does not increase with flow rate are unpredictable and 
are found in flexible valves when there is a concomitant increase in EOA.. 
These data demonstrate that resistance is finally of very limited utility for the 
characterization of aortic stenosis severity or prosthetic valve function. 
4:30 p.m. 
893-3 Low Gradient Aortic Stenosis: Is There a Role for 
Dobutamine Echocardiography? 
Alfred0 Zuppiroli, Fabio Mori, Mauro Bini, Silvia Favilli, Gabriele Castelli, 
Albert0 Dolara. CardiologiaZ, Ospedele Careggi, Firenze, Ma/y 
Background: Severe aortic stenosis (AS) and left ventricular (LV) dysfunc- 
tion is a challenge either from a diagnostic point of view (true anatomic AS or 
reduced valve opening due to low flow?) or a prognostic one (who is likely to 
benefit from surgery?). Therefore, feasibility and potential role of dobutamine 
echocardiography (DE) in decision making in patients (p) with severe AS 
(aortic valve area - AVA - 5 0.5 cm2/m2), LV dysfunction (EF 5 0.40) and 
low mean gradient (530 mmHg) were studied. 
Methods: Thirtynine p underwent DE with an initial dose of 5 pg/kg/min, 
increasing by 5 pg/kg/min every 5 minutes up to a maximal dose of 20 
bg/kg/min. An LV contractile reserve (LVCR) was defined as an improvement 
of LV EF ? 30%. In p with LVCR an AVA increasing ~0.25 cm2 was defined 
as relative AS (RAS), otherwise AS was considered as fixed (FAS). 
Results: Two p were excluded because of poor quality images; in the 
remaining 37 p DE was interrupted in 2 due to not sustained VT or synus 
bradycardia; no major complications occurred. All LVCR was elicited in 26 
p (70%); among these 19 (73%) had FAS and 7 (27%) had RAS. During 
follow-up (18 It 9 months) 3 p underwent percutaneous aortic valvuloplasty 
due to extremely severe conditions and were excluded from further analysis; 
valve replacement was performed in 12 p (group A), 22 were medically 
treated (group B). Mortality was significantly lower in group A (3/12, 8%) vs 
group B (11/22, 50%; p = 0.024, OR = 3.07). Because indication to surgery 
was partially independent from DE results, some RAS were operated and 
some FAS were not (group A: LVCR 10/12, 83%; FAS 8, RAS 2; group B: 
LVCR 14/22,64%: FAS 9, RAS 5). 
Conclusions: 1) p with severe AS and LV dysfunction have a very poor 
prognosis if not operated. 2) DE is a feasible and safe test in this setting and 
may play a role in the detection of p with LVCR and FAS where surgery can 
be dramatically beneficial. 
4:45 p.m. 
893-4 Is Prophylactic Aortic Valve Replacement Indicated 
in Patients Who Undergoing Mitral Valve 
Replacement Presented With a Coexisting Mild to 
Moderate Aortic Valvular Disease? 
Seung Hyuk Choi, Jong-Won Ha, Byung-Chul Chang, Namsik Chung, 
Won-Heum Shim, Seung-Yun Cho, Sung Soon Kim. Yonsei University 
Coiege of Medicine, Seoul, Korea 
Background: A considerable proportion of patients who require mitral valve 
(MV) replacement present with a coexisting pathology of the aortic valve 
(AV). However, combined AV and MV replacement is associated with higher 
operative risk and poorer long-term survival than MV replacement only. Little 
is known about the natural history of AV disease in patients undergoing MV 
surgery. The purpose of this study was to evaluate the long-term course of 
AV disease and the need for AV surgery in patients who have undergone MV 
surgery. 
Methods: One hundred forty-one pts (44 M, mean age 43 yrs) with mild 
to moderate AV disease and severe rheumatic MV disease were treated with 
MV surgery. The patients were followed for an average period of 8 f 3 yrs 
(range 1-16) after MV replacement. 
Results: At the time of MV surgery, 104 pts (73.8%) had mild aortic 
regurgitation (AR), 37 pts (36.2%) moderate AR, 5 pts (3.5%) mild aortic 
stenosis (AS) and 2 pts (1.4%) moderate AS. At the end of follow-up period, 
no pts had severe AV disease. Six pts (4.3%) died during the follow-up, and 
three pts (2.1%) treated with AV replacement (AVR) after a mean period 
of 9 years: One pt (0.7%) with prosthetic MV failure and moderate AR (G 
Ill) needed redo-MVR and AVR. Two symptomatic (NYHA Ill) pts (1.4%) 
with moderate AS needed AVR. Survival analysis with Kaplan-Meier method 
revealed IO-year survival rates of 95.5% and IO-year AVR free survival rates 
of 96.8%. 
YE/\RS YEARS 
Conclusion: These data suggest, most of the patients who have mild AV 
disease at the time of MV surgery, AV replacement is rarely needed after a 
long follow-up period. Thus, prophylactic AV replacement is not indicated in 
these patients. 
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I 1205 63 Determinants of Acute and Long-Term Survival in 245 Patients With Infective Endocarditis 
Gerald S. Werner’, Barbara M. Richartz’, Seda Schiinemanns. 
’ Friedrich-Schiller-University, Jena; ‘Georg-August-UniversiM Goettingen, 
Germany 
Background: Infective endocarditis (IE) still has a high mortality. This study 
should analyze the determinants of adverse outcome of IE in the acute phase 
of the disease, and during a 5 year follow-up. 
Patients and Methods: 245 Patients with a definite diagnosis of IE ac- 
cording to the modified Dukes criteria were enrolled in a registry of IE treated 
at a tertiary referral center in central Germany from 1990-97. Median age 
was 60 (18-91). Late prosthetic valve IE (PVE) was present in 24%, early 
PVE was excluded. All surviving patients were followed for a mean time of 
43 f 24 months. Cox-Hazard regression analysis was done for independent 
determinants of survival. Among the variables tested were age, PVE, double- 
valve infection, presence of fever, embolism, echocardiographic detection of 
vegetation, staphylococcal infection, and surgical therapy. 
Results: In-hospital mortality was 23.7%. The subgroup analysis demon- 
strated the highest in-hospital mortality in the presence of cerebral embolism 
with 47%, with staph.aureus it was 42%, and with double valve infection it was 
40%. Major determinants of mortality were double valve infection, embolism, 
and staph.aureus infection. Surgical therapy was performed in 61% after a 
median 34 days after the diagnosis. When surgical therapy was entered into 
the survival analysis, it was the best positive predictor of survival (Chi2 = 14), 
even in the presence of cerebral embolism. 2-year mortality with surgery was 
22%, with medical therapy it was 47% (p < 0.001). The advantage of surgical 
therapy was highest in the presence of complications (25% vs. 61%). The 
annual mortality after hospital discharge was 5.8%. The major determinant 
for late mortality was double-valve infection. 
Conclusion: IE carried a high in-hospital mortality, with a moderate long 
term mortality. A liberal indication of surgical therapy in the acute phase 
appears to be a promising therapeutic option. 
I 1205 64 Predictive Factors of Systemic Embolism in Left-Sided Infective Endocarditis 
Christine Selton-Suty, Thanh Lecompte, Philippe Houplon, Jean P. Preiss, 
Ahcene Ammad, Philippe Canton, Bruno Hoen, Yves Juilliere. Cardiology, 
CHU Nancy-Brabois, France 
Background: Systemic embolism frequently occurs in left-sided infective en- 
docarditis (IE) and prevention of subsequent irreversible organ dysfunction 
is a desirable goal. Our study aimed to assess the clinical and bacteriological 
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features of IE associated with embolism in order to determine the predictive 
factors of occurrence of this event. 
Methods: From Nov. 1990 to Dec. 1997, 219 consecutive pts were ad- 
mitted to our institution for IE. Among them, 176 pts presented with left-sided 
definite IE according to the Duke criteria. The 47 pts with embolic events (grl, 
33 M/14 F) were compared to the 129 embolism-free pts (gr2, 83 M/46F). 
Results: Site of embolism was CNS in 31 pts, peripheral arteries in 19 
pts, and other organs in 10 pts. Gr 1 pts were significantly younger than gr 2 
pts (54 * 14 vs 60 & 17 yrs, p = 0.02) and had less frequently a preexisting 
heart disease (38% vs 45%, p = 0.002). Clinical signs and symptoms, the 
location of endocarditis, the existence of a significant regurgitation or of a ring 
abscess were similar in the two groups. Proportion of cases with negative 
blood culture, general distribution of causative micro-organisms did not differ 
between both groups. However, among streptococci, viridans species were 
less frequently present in gr 1 (33% vs 44%) than pyogenic streptococci 
(29% vs 8%) and S. bovis and enterococci (38% vs 48%) (p < 0.05). TFE 
and/or TEE evidenced a vegetation in 94% gr 1 pts vs 82% gr 2 pts (p = 0.06), 
and vegetations were more frequently >I0 mm in gr 1 than in gr 2 (85% vs 
57%, p = 0.004). Clinical course during hospitalization (duration of hospital 
stay, need for surgery 51% vs 44%, mortality: 19% vs 24%) was similar in 
the 2 groups. Among all pts, multivariate analysis showed that the absence 
era preexisting heart disease (OR: 2.4, 95%CI [1.1-4.8], p = 0.02) age (OR: 
1.02, 95%CI [I .0-l ,051, p = 0.03) were the only significant predictive factors 
of embolism. When considering only patients with an echocardiographically 
detectable vegetation, the size of this vegetation > IO mm became the only 
significant factor (OR: 3.6, 95%CI [1.3-10.31, p = 0.02) 
Conclusion: Embolic events in IE occur frequently in young pts without 
preexisting heart disease and with a large vegetation at echocardiography. 
Early surgery might be discussed in thee pts in order to avoid embolism. 
I 1205 65 Clinical Course of Infective Endocarditis in the Years 1996-l 998 Preliminary Results of the ALKK 
Endocarditis Registry 
0. Benetka, M. Block, 0. Sangha, F. Praetorius, R. Uebis, K.L. Neuhaus. R. 
v. Essen for the ALKK (Arbeitskreis leitender kardiologischer 
KrankenhausPrzte), Germany 
Background: Recent multicenter clinical data on infective endocarditis (IE) 
are not available. Therefore cases of IE were enrolled in a prospective registry 
between i/96 and 12/98 by German nonuniversity cardiology departements. 
Method: 704 pts. from 69 hospitals were evaluated using a standardized 
2 paged questionnaire with more than 70 parameters e. g. patients demo- 
graphics, predisposing factors of IE, actual manifestation, symptomatology, 
diagnostic and therapeutic procedures, outcome after hospitalisation. 
Results: On average pts. were 61 f 15 years old, 61% were male. First 
symptoms of IE occurred already 43 & 38 days prior to diagnosis. 49% of 
pts. had a known valvular disease, in 44% of pts. there was a presumed 
portal of entry (skin 17%, dental sources 8%, GI-tract 6.7%). 33% of patients 
developed hear-l failure NYHA class Ill or IV, 19% showed central nervous 
symptoms, 14% a splenomegaly and 9% skin lesions. IE was equally often 
located on mitral valve and aortic valve (51.7 and 50.4%). The Tricuspid 
valve was only affected in 8% of our pts.. Altrough in the majority of cases 
native valves were infected. In 12% of pts. we found infected mechanic 
valves, tissue prothesis were infected in 7% in the aorticposition and in 2% 
of pts. in the mitralposition. Infected reconstructed valves were found only in 
the mitralposition in 2% of infected mitral valves. 27% of pts. had negative 
blood cultures. In pts. with positive blood cultures on average 3.4 of 6.3 were 
positive. Streptococci were found in 27% of patients, Staph. aureus in 21% 
and Enterococci in 10%. 30% of all pts. had to be treated without an antibiotic 
resistogramm. Most pts. had definitive documentation of vegetations by TEE 
(72%). During the course of IE 18% of all pts. died, 36% suffered heart failure 
NYHA Class Ill or IV, 38% showed an embolic episode, 26% a septic state 
and 33% of pts. received earely valvular replacement. 
Conclusion: IE is still in the late nineties often a serious disease with 
a high lethality and complication rates. Often the diagnosis is missed for 
several weeks and many pts. are treated without an antibiotic resistogramm 
treat 
1 1205-66 1 Factors Associated With Increased Morbidity and 
Mortality in the Initial Assessment of Patients 
Presenting With Acute Infective Endocarditis 
Ben I. Walton, Sharon M. Wallace, Rajesh Kharbanda, Rebecca Hardy, 
Andrew P. Wilson, Ft. Howard Swanton. University College Hospitals, 
London, UK 
Background: Despite many advances in the management of infective en- 
docarditis (IE) the overall morbidity and mortality of this condition remains 
high and rises still further in certain sub groups of patients. We undertook 
this study to examine whether it was possible to identify these high risk sub 
groups on the day of presentation to hospital thus aiding management. 
Methods: 201 consecutive patients with IE presenting to a Cardiology 
Tertiary Referral Centre between 1981 and 1999 were retrospectively studied. 
40.8% of these were transferred from other hospitals. Patient demographics 
were obtained and variables from the day of admission into hospital were 
examined using unadjusted and adjusted logistic regression. Outcome was 
defined as mortality at discharge from hospital and mortality at 6 months. 
Results: Mean age was 52 years. 68 (33.8%) were female and 133 
(66.2%) male. Diagnosis was made using the Duke criteria (187 (93%) 
positive, 14 (7%) negative) and findings at surgery and post-mortem where 
available. 86.6% were culture posrtive and 13.4% culture negative. In 22.4% 
the infecting organism was Staphylococcus Aureus. Native valve endocarditis 
was present in 137 (68.2%) and Prosthetic valve endocarditis in 62 (30.8%). 
Valves infected were Aortic alone (83 cases, 41.3%) Mitral alone (71,35.3%), 
Tricuspid alone (18, 9%) and others including multiple valves (29, 14.4%). 
Mortality at discharge and at 6 months was 19.4% and 28.2% respectively. 
Risk factors, identified by adjusted logistic regression, for increased mortality 
at discharge were; 1) abnormal White Cell Count (WCC) (Odds ratio 9. IO, p 
= O.OOl), 2) normal Erythrocyte Sedimentation Rate (ESR) (Odds ratio 4.55, 
p = 0.04) and 3) abnormal Serum Albumin (SA) (Odds ratio 3.17, p = 0.04). 
When mortality figures at 6 months were examined these factors remained 
significant; abnormal WCC (Odds ratio 4.03, p = O.Ol), normal ESR (Odds 
ratio 3.70, p = 0.06) and abnormal SA (Odds ratio 2.76, p = 0.04). 
Conclusions: We have demonstrated that simple blood parameters ob- 
tained on admission to hospital allow the identification of patients who are at 
much greater risk of death from IE. This may for allow early and more ag- 
gressive intervention (including transfer to a specialist centre) in these high 
risk sub groups so improving outcome in what remains a difficult disease to 
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